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 The ability to sense metabolic status and coordinately regulate specific aspects of 
metabolism is central to human health and disease. The second chapter of this dissertation 
defines a role for the Drosophila nuclear receptor, DHR96, as a key regulator that 
coordinates triacylglycerol (TAG) and cholesterol homeostasis. Studies presented in this 
dissertation show that DHR96 maintains whole animal TAG levels by promoting the 
breakdown of dietary TAG through regulation of the intestinal lipase Magro.  Previous 
studies have shown that DHR96 binds cholesterol in its ligand-binding domain and 
regulates the transcriptional response to dietary cholesterol. The third chapter of this 
dissertation describes how, in conjunction with its role in promoting dietary TAG 
digestion, DHR96 functions through magro to prevent the accumulation of excess sterols 
in the fly. Magro exerts this role in cholesterol homeostasis through its cholesterol 
esterase activity, cleaving stored cholesterol esters to promote sterol excretion. Taken 
together, these studies define a key role for DHR96 in coordinating dietary TAG 
digestion and maintaining cholesterol homeostasis through its regulation of magro. 
Observations made during my studies of Drosophila lipid metabolism suggested that the 
metabolic state of the progeny is dependent on the health and nutritional status of their 
parents. The fourth chapter of this dissertation shows that temporary dietary restriction 
during the parental 
iv	  
generation influences TAG and glycogen levels in the resulting progeny, as well as 
specific changes in metabolic gene expression. This work also defines roles for both  
DHR96 and HP1 as key regulators of these transgenerational effects on metabolism, 
suggesting that transcriptional regulation and chromatin are a central part of this pathway. 
Overall, these studies establish a new genetic system and framework for detailed 
molecular characterization of the mechanisms that facilitate the transgenerational 
regulation of metabolism, including an investigation of nuclear receptor and chromatin 
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Triacylglycerol (TAG) and cholesterol homeostasis is maintained by balancing 
dietary lipid uptake and synthesis with lipid catabolism and excretion (Ikonen, 2008; 
Lusis and Pajukanta, 2008). Under normal feeding conditions, TAG and cholesterol are 
either synthesized or absorbed from the diet. These lipids can then be packaged in 
lipoprotein particles that are released into the circulatory system as a means to distribute 
them throughout the body. These trafficked lipids are either utilized by cells for the 
production of signaling molecules, membrane components, or deposited in storage tissues 
such as adipose tissue or the liver. When needed by cells, stored TAG and cholesterol 
esters can be broken down and utilized for energy production, or excreted to remove 
excess lipids.  
Disruptions in lipid regulatory mechanisms have been implicated in a number of 
human diseases ranging from neurological disorders, such as Niemann-Pick Type C 
disease, to other more systemic conditions such as diabetes, obesity, and coronary heart 
disease. As a result, there has been a concerted effort in model system research to identify 
the regulatory factors that maintain lipid homeostasis. These studies have identified 
SREBP and LXR as key transcription factors that control lipid synthesis and cholesterol 
excretion	  (Briggs et al., 1993; Hua et al., 1993; Janowski et al., 1996; Peet et al., 1998; 
Wang et al., 1993; Yokoyama et al., 1993). Despite these studies, little is known about 
how the target genes of these transcription factors coordinate the complex physiological 





SREBP-mediated control of TAG and cholesterol homeostasis  
One of the best characterized factors that coordinates cholesterol and TAG 
metabolism is the SREBP signaling pathway. SREBP-1c and SREBP2 encode helix-loop-
helix leucine zipper transcription factors that localize to the endoplasmic reticulum (Hua 
et al., 1993; Yokoyama et al., 1993). When cellular cholesterol levels decrease, SREBPs 
are activated by a series of proteolytic cleavage events that release the N-terminal domain 
from the ER.  The cleaved protein enters the nucleus where it activates the expression of 
target genes involved in cholesterol and triglyceride metabolism (Wang et al., 1994). 
SREBP-1c controls the fatty acid and TAG synthesis branch of the SREBP signaling 
pathway by regulating the expression of key enzymes like Acyl-CoA synthase (ACC) and 
fatty acid synthase (FAS) (Figure 1.1 and 1.2) (Bennett et al., 1995; Briggs et al., 1993; 
Magana et al., 1997; Wang et al., 1993). In contrast, SREBP2 controls the cholesterol 
synthesis arm of the pathway through direct regulation of HMG-CoA reductase and 
several other enzymes in the cholesterol synthesis pathway (Figure 1.2) (Vallett et al., 
1996). SREBP activation promotes de novo TAG and cholesterol synthesis as well as 
increased lipid uptake by the cell, providing a means of coordinating cellular lipid status 
with TAG and cholesterol homeostasis (Osborne, 2000; Vallett et al., 1996). Despite 
detailed studies of this pathway, much remains to be learned about the factors that 










Figure 1.2 The SREBP signaling pathways 
  
Under conditions of low cellular cholesterol levels, both SREBP2 and SREBP-1c are 
cleaved and enter the nucleus to activate the expression of genes involved in cholesterol 
and fatty acid/TAG synthesis, respectively.   
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Regulation of TAG and cholesterol homeostasis by the LXR 
subclass of nuclear receptors 
Nuclear receptors (NRs) are ligand-regulated transcription factors that play 
central roles in multiple aspects of lipid metabolism. Many NRs bind small lipophilic 
compounds, such as fatty acids, sterols, and bile acids, and direct specific changes in gene 
expression. One example of this is LXRα (NR1H3), which binds oxysterols in its ligand 
binding domain and regulates both TAG and cholesterol metabolism (Janowski et al., 
1996; Kalaany and Mangelsdorf, 2006). Mutants lacking LXRα display elevated levels of 
circulating and stored cholesterol in the liver. LXRα maintains cholesterol homeostasis 
through direct regulation of bile salt production through the CYP7A2 bile acid 
biosynthetic enzyme, and bile excretion through the ABCG5/ABCG8 bile acid 
transporters (Figure 1.3) (Repa et al., 2002). Genetic studies have shown that LXRαβ 
double mutant mice, while displaying normal body weight and body fat, are resistant to 
diet-induced obesity, also implicating a role for this receptor in TAG metabolism. 
LXRs function in the liver to maintain TAG homeostasis by controlling fat synthesis and 
uptake, in part, through direct transcriptional regulation of the key lipogenic transcription 
factor SREBP-1c (Figure 1.3) (Schultz et al., 2000).  
 LXR activity is thus central to both TAG and cholesterol homeostasis, although 
much remains to be learned about the roles of specific LXR target genes in mediating 
these key metabolic functions. 
In addition to its role in the liver, recent work has identified an important role for 
LXRs in the regulation of cholesterol excretion in the intestine. LXR activation in this 




Figure 1.3 LXRs coordinate cholesterol and TAG homeostasis 
 
In response to increasing oxysterol levels, LXRs are activated in the liver, inducing the  
expression of genes involved in hepatobiliary cholesterol excretion and liver fatty acid/ 
TAG synthesis.  
 
expression of the ABCG5/ABCG8 bile acid transporter (Lo Sasso et al., 2010; van der 
Veen et al., 2009). This observation suggests that LXR promotes reverse cholesterol  
transport in this tissue, which represents one of the best-characterized mechanisms for 
eliminating excess cholesterol from the body. Reverse cholesterol transport involves 
HDL-mediated transport of cholesterol from peripheral tissues to the hepatobiliary tract, 
leading to the removal of excess sterol by biliary excretion from the body. LXR 
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activation of fecal sterol excretion, however, proceeds normally in abcb4 mutant mice, 
which have severely impaired biliary cholesterol secretion (Kruit et al., 2005). Similarly, 
abcg5/abcg8 double mutants, which have highly reduced biliary cholesterol excretion, 
have relatively normal levels of fecal sterols (Yu et al., 2002).  These and other studies 
have challenged the importance of reverse cholesterol transport for cholesterol excretion 
and have led to the proposal that the intestine may play a more direct role in this process 
(van der Velde et al., 2010; van der Velde et al., 2007). Indeed, intestinal perfusion 
studies in mice have demonstrated that up to 60% of fecal sterols can be excreted directly 
from the proximal intestine (van der Velde et al., 2007). Taken together, these studies are 
shifting the focus of cholesterol efflux toward the intestine and implicate a central role for 
LXR in regulating this poorly understood pathway.   
 
LipA-mediated TAG and cholesterol homeostasis  
While there have been numerous studies of the transcriptional regulation of lipid 
metabolism, some enzymes can also play a central role in coordinating cholesterol and 
TAG homeostasis. For example, the LipA/LAL gene, which encodes an acid lipase, is 
mutated in patients suffering from cholesterol ester storage disease (CESD) and 
Wolman’s disease (Burke and Schubert, 1972; Goldstein et al., 1975; Pisciotta et al., 
2009).  These patients exhibit digestive difficulties and have significantly reduced 
deposits of white adipose tissue, while at the same time displaying increased TAG and 
cholesterol accumulation in the liver and spleen (Crocker et al., 1965; Kyriakides et al., 
1970; Ozsoylu et al., 1977; Pisciotta et al., 2009). Similar effects have been seen in 
genetic studies of LipA null mutant mice (Du et al., 1998; Du et al., 2001). Biochemical 
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studies of LipA have demonstrated that it acts as a dual function enzyme with both 
cholesterol esterase and TAG lipase activity (Ameis et al., 1994; Goldstein et al., 1975), 
suggesting that it may directly impact both TAG and cholesterol metabolism. Studies of 
macrophage cholesterol efflux have shown that this enzyme breaks down stored 
cholesterol esters as a means of promoting ABCA1-mediated cholesterol efflux (Ouimet 
et al., 2011). Roles for LipA in TAG homeostasis, however, remain to be determined.  
 
Drosophila as a simple system for studying TAG metabolism 
 The complex nature of metabolic disorders has made it difficult to determine the 
physiological mechanisms that control lipid homeostasis. Given the advanced genetic 
tools available, and the fact that many metabolic regulatory pathways are conserved from 
flies to humans, Drosophila provides a simple system for the physiological and molecular 
characterization of the mechanisms that maintain metabolic homeostasis (Baker and 
Thummel, 2007; Kuhnlein, 2010). This was initially seen in studies of the Drosophila 
adipose gene, which was identified in genetic studies of a naturally-occurring obese fly 
stain.  Mutants lacking adipose function exhibit a significant increase in whole animal 
TAG levels (Doane, 1960). Subsequent studies have shown that adipose acts in a dose 
dependent manner. It appears to antagonize TAG accumulation and TAG synthesis in 
both flies and mice, through interactions with histones and HDAC3 to modulate 
chromatin state (Suh et al., 2007). Mutations in adipose have also been associated with 
obesity in humans (Lai et al., 2009). This work highlights the use of Drosophila as an 
ideal system for the discovery of novel TAG regulatory mechanisms that are conserved 
through evolution, from flies to humans. Genetic studies of lipid metabolism in 
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Drosophila, however, have only been underway for a few years. Below I discuss some 
major advances in this area, outlining roles for key regulators such as SREBP, Seipin, 
and factors involved in lipid storage, breakdown, and transport. 
 Fatty acid synthesis metabolism in Drosophila, as in mammals, initiates with 
acetyl-CoA precursors through the activity of ACC and FAS (Figure1.1). Free fatty acids 
are then activated by acyl-CoA synthase and esterified to a glycerol backbone, producing 
acylglycerol lipids such as diacylglycerol (DAG) and TAG, the circulating and stored 
form of fat in the fly. Interestingly, SREBP has been identified as a key transcriptional 
regulator that controls the expression of all three enzymes in this lipid biosynthetic 
pathway in Drosophila (Figure 1.1).  SREBP mutants arrest in the second larval instar 
and exhibit decreased levels of TAG and fatty acid synthesis	  (Kunte et al., 2006). 
Furthermore, SREBP activity is stimulated by fatty acids, such as palmitate, and appears 
to function in multiple key metabolic tissues such as the fat body, intestine, and the 
oenocytes, indicating a role in the nutrient-dependent control of lipid metabolism	  
(Seegmiller et al., 2002).  
Mutations in the Berardinelli-Seip Congenital Lipodystrophy (BSCL) gene, 
BSCL2, in mammals are associated with a severe form of lipodystrophy where patients 
display severely depleted peripheral white adipose tissue (WAT) as well as ectopic lipid 
accumulation in nonlipid storage tissues such as muscle (Magre et al., 2001). Subsequent 
genetic studies of seipin, the Drosophila ortholog of BSCL2, have shown that mutants 
lacking seipin function display an 80% decrease in whole animal acylglycerols with 
ectopic lipid accumulation in the salivary glands. These defects result from of a block in 
phosphatidic acid utilization in the mutants and suggest a role for seipin in the early steps 
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of TAG synthesis, although the precise mechanisms remain to be determined (Tian et al., 
2011).   
In mammals, lipid trafficking is facilitated by lipoprotein particles composed of 
various lipids (TAG, cholesterol, cholesterol esters, phospholipids) and apolipoproteins 
that function as carriers. RfaBp/lipophorin (Lpp) mediates this lipoprotein carrier function 
in Drosophila. Animals lacking Lpp function display defective lipid accumulation in a 
number of tissues, including the fat body, midgut, and imaginal discs (Eugster et al., 
2007; Panakova et al., 2005). These studies also indicate that Lpp is required for long-
range Wnt and Hedgehog signaling. Once in circulation these lipoprotein particles are 
bound and absorbed by peripheral tissues so that the lipids they carry can be stored and/or 
utilized. Recent work has identified lpr1 and lpr2 as key membrane receptors that 
mediate the uptake of lipophorin particles in the ovary and imaginal discs (Parra-Peralbo 
and Culi, 2011). No significant changes, however, were observed in fat body lipid 
accumulation. These data suggest that a major source of fat body lipids derives from de 
novo fat synthesis and not from dietary lipids, although the source of these lipids has yet 
to be determined.  
Once TAG is synthesized and trafficked to storage tissues such as the fat body 
and intestine, it is deposited in lipid droplets. This process of lipid storage requires the 
opposing functions of the lipid droplet surface proteins, plin1 and plin2, which are 
members of the perilipin family of proteins. In mammals, perilipins facilitate TAG 
storage through interactions with two key TAG lipases, hormone sensitive lipase (HSL) 
and adipose triglyceride lipase (ATGL) (Brasaemle, 2007). Mutants lacking plin1, are 
obese, displaying a 2-fold increase in TAG levels and a significant increase in lipid 
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droplet size (Beller et al., 2010). In contrast, plin2 mutants display a ~35% decrease in 
whole animal TAG, consistent with its conserved role in antagonizing fat body lipolysis 
(Fauny et al., 2005; Gronke et al., 2003). Taken together, these studies suggest that the 
opposing functions of plin1 and plin2 control a balance between TAG storage and 
mobilization that is required to maintain whole animal lipid homeostasis. The precise 
molecular mechanisms by which plin1 and plin2 modulate TAG levels, however, have 
yet to be determined.   
Stored TAG can be mobilized from lipid droplets by the activity of fat body TAG 
lipases to facilitate trafficking and utilization by peripheral tissues. Genetic studies of the 
Drosophila ATGL homolog, brummer, have shown that these mutants are severely obese 
as a result of their inability to breakdown stored TAG in the fat body	  (Gronke et al., 
2005). Furthermore, analysis of plin2;bmm double mutants has shown that these null 
mutations mutually suppress each other, displaying an intermediate TAG phenotype. 
These results suggest that these genes function through parallel mechanisms to maintain 
TAG homeostasis. In addition, while critical for fat body TAG lipolysis, brummer 
mutants still exhibit significant starvation-induced fat body lipolysis, suggesting that 
there may be multiple mechanisms for the breakdown of stored TAG (Gronke et al., 
2005). Recent data have identified a parallel lipolytic mechanism regulated by 
adipokinetic hormone (AKH) signaling, a pathway similar to the glucagon signaling 
pathway in mammals, that functions in the early stages of starvation to promote TAG 
breakdown (Gronke et al., 2007; Lee and Park, 2004). In the absence of both AKH 
signaling and brummer function, starvation-induced TAG lipolysis is lost, indicating that 
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these two pathways provide the primary means of fat body lipolysis in the fly, similar to 
the functions of HSL and ATGL in mammals (Gronke et al., 2007; Schweiger et al., 2006). 
The free fatty acids that derive from TAG lipolysis can be utilized for energy 
production through the process of mitochondrial fatty acid β-oxidation. In this process, 
fatty acids are broken down into acetyl-CoA that enters the TCA cycle, driving oxidative 
phosphorylation to produce ATP.  While fatty acid β-oxidation functions constitutively at 
low levels, maximal ATP production through β-oxidation and oxidative phosphorylation 
requires the transcriptional induction of key rate-limiting enzymes such as CPT1 
(carnitine acyltransferases) by the nuclear receptor HNF4 in Drosophila (Palanker et al., 
2009). Under starvation conditions, free fatty acids are released and can be bound by the 
ligand-binding domain of HNF4, activating the receptor (Palanker et al., 2009; Wisely et 
al., 2002). Once activated, HNF4 stimulates a feed-forward pathway that induces the 
expression of fatty acid β-oxidation enzymes as well as TAG lipases, promoting fat 
breakdown and energy production (Palanker et al., 2009). While HNF4 mutants display 
normal TAG and fatty acid levels under fed conditions, starved HNF4 mutants exhibit 
higher levels of both TAG and fatty acids, consistent with a block in TAG mobilization 
and β-oxidation. These data demonstrate a role for HNF4 in promoting maximal TAG 
oxidation during starvation and suggest that alternative mechanisms regulate lipid 
oxidation under fed conditions.  
Although these studies provide a good foundation for understanding the 
regulation of lipid homeostasis in Drosophila, a number of areas require further research. 
For example, although SREBP exhibits a conserved role in controlling fatty acid and 
triglyceride synthesis through its regulation of ACC, ACS, and FAS expression, much is 
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still unknown about the global role of SREBP in the transcriptional control of lipid 
homeostasis, as well as the precise signals that facilitate its cleavage and activation in 
Drosophila. In addition, aspects of lipid metabolism such as the intracellular trafficking 
of lipids, lipophorin particle assembly, and the content, secretion, and absorption of 
lipoprotein particles by peripheral tissues, remain unclear. Furthermore, although 
overexpression of insulin-like proteins in Drosophila stimulates whole animal TAG 
accumulation, the mechanisms that underlie insulin-mediated inhibition of lipolysis have 
not been defined (Arquier et al., 2008; Carnie et al., 1979).  Finally, surprisingly little is 
known about the transcriptional regulatory mechanisms that facilitate nutrient digestion 
and absorption in response to feeding.  
 
Regulation of cholesterol homeostasis in Drosophila 
Cholesterol metabolism begins with the synthesis of cholesterol from acetyl-CoA 
precursors through the mevalonate and steroid biosynthetic pathway. Drosophila, despite 
having a functional mevalonate pathway, are unable to synthesize cholesterol de novo. 
This is a result of the fly lacking several key enzymes downstream of farnesyl 
pyrophosphate synthase in the conversion of mevalonate into cholesterol	  (Vinci et al., 
2008). As a result, Drosophila are complete cholesterol auxotrophs and must rely on the 
absorption and conversion of dietary sterols for survival (Sang, 1956). In mammals, 
cholesterol absorption is facilitated by the Niemann-Pick type C1-like protein NPC1L1. 
Recent work has shown that the fly NPC1L1 ortholog, NPC1b, plays a similar role in the 
midgut to mediate the absorption of dietary sterols. Mutants lacking NPC1b die during 
the second larval instar as a result of defective sterol absorption (Voght et al., 2007). 
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NPC1b mutants, however, do not exhibit changes in whole animal cholesterol levels, 
suggesting that there are additional mechanisms for sterol uptake present in the fly, and 
that NPC1b may have additional uncharacterized functions that may account for the 
lethality of NPC1b mutants.  
Bulk sterols are trafficked through the ER and Golgi to be stored in lipid droplets, 
trafficked to the membrane, or packaged for release into the circulatory system to be 
distributed throughout the body. The NPC2 family of proteins have been implicated as 
key factors required for subcellular sterol trafficking in both flies and mammals. While 
mice encode a single NPC2 gene in their genome, Drosophila have eight members of this 
family, NPC2a-h.  Initial studies of the NPC2 genes in the fly indicate that mutants 
lacking NPC2a or NPC2b die during larval development and exhibit neuronal defects 
(Huang et al., 2007). Furthermore, when stained with the sterol-specific compound filipin, 
NPC2a mutants exhibit a punctate subcellular pattern indicative of a defect in cholesterol 
trafficking (Huang et al., 2007). Double mutant analysis suggests that NPC2a and NPC2b 
function in a semiredundant manner to promote cholesterol trafficking and utilization 
within the cell. Furthermore, the lethal phenotype observed in these double mutants can 
be suppressed by feeding excess cholesterol or the insect steroid hormone 20-
hydroxyecdysone, indicating that steroid hormone production is restricted by the amount 
of available cholesterol.  
The Drosophila ortholog of mammalian NPC1, NPC1a, exhibits a conserved role 
in intracellular post-lysosomal trafficking of sterols. NPC1a mutants display defective 
cholesterol trafficking as well as larval lethality (Fluegel et al., 2006). Moreover, this 
lethal phase can be suppressed by feeding 20-hydroxyecdysone, suggesting that NPC1a 
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functions with NPC2 proteins to mediate intracellular lipid trafficking. While these data 
are consistent with roles in cholesterol trafficking, however, little is known about the 
precise functions of these proteins. For example, it would be interesting to determine if 
these proteins act through a hydrophobic hand-off mechanism, whereby NPC2 directly 
transfers cholesterol to membrane bound NPC1, as described in mammals (Wang et al., 
2010).  
In addition to this role in cholesterol trafficking, the Drosophila NPC1 ortholog, 
NPC1a, appears to act in a parallel pathway to prevent intestinal cholesterol absorption 
(Wang et al., 2010; Xie et al., 1999). NPC1a mutants display elevated levels of 
cholesterol absorption, although the cause of this phenotype is unknown (Fluegel et al., 
2006).  Thus, while NPC1b functions to facilitate cholesterol absorption, NPC1a 
antagonizes cholesterol absorption. This model is supported by genetic analysis, which 
shows that null mutations in these two genes result in mutual suppression of their 
respective cholesterol absorption defects, yielding an intermediate phenotype. This 
observation suggests that NPC1a and NPC1b act in parallel to control sterol absorption. 
No changes in total cholesterol levels, however, were observed in either NPC1a or 
NPC1b mutants, indicating that these genes may have additional roles in cholesterol 
utilization that may account for the lethal phenotype of the mutants (Voght et al., 2007). 
More studies are required to define the precise mechanisms by which these NPC family 
members control cholesterol absorption and trafficking.  
A major advance in understanding the regulation of cholesterol metabolism in 
Drosophila arose from biochemical and genetic characterization of the LXR nuclear 
receptor homolog, DHR96. In response to high levels of dietary cholesterol, DHR96 
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binds cholesterol in its ligand binding domain, much like LXR. DHR96 mutants are lean 
and exhibit elevated levels of dietary cholesterol (Bujold et al., 2010; Horner et al., 2009; 
Sieber and Thummel, 2009). Microarray studies have identified a number of target genes 
for this receptor, many of which are expressed in the intestine and are predicted to 
function in lipid metabolism. These include CG8112, which encodes a predicted acyl 
CoA: cholesterol acetyltransferase (ACAT), CG6472, which encodes a homolog of 
lipoprotein lipase (LPL), the NPC2 family orthologs npc2b, npc2c, and npc2d, as well as 
a LipA homolog magro (CG5932) (Bujold et al., 2010; Horner et al., 2009; Sieber and 
Thummel, 2009). Functional studies of one of these targets, NPC1b, demonstrated that its 
lack of repression in DHR96 mutants could account for the elevated sterol levels seen in 
these animals when they are maintained on a high cholesterol diet (Horner et al., 2009). 
DHR96 mutants, however, do not show an overt defect in cholesterol absorption, 
indicating that this receptor likely functions to maintain cholesterol levels through the 
regulation of multiple aspects of cholesterol homeostasis. In addition, further studies are 
required to define roles for DHR96 in the regulation of TAG metabolism. 
 
Thesis summary  
 In this dissertation I present my studies of DHR96 and its direct target gene, the 
LipA homolog magro (CG5932). In Chapter 2, I describe how Drosophila DHR96 
regulates whole animal TAG homeostasis through the gastric lipase activity of Magro. 
Mutants lacking DHR96 are lean, starvation sensitive, and resistant to diet-induced 
obesity. This decrease in whole animal TAG levels is correlated with a dramatic 
reduction in magro expression in the intestine. Midgut-specific expression of magro is 
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sufficient to rescue the DHR96 mutant lean phenotype, demonstrating that this lipase 
plays a key role in the DHR96 signaling pathway and identifying DHR96 as a novel 
nutrient-responsive transcriptional regulator of dietary lipid metabolism.  
 In Chapter 3, I expand my studies of DHR96 and magro by examining their roles 
in coordinating TAG and cholesterol homeostasis. In addition to better defining the 
regulation of dietary TAG metabolism, this work identifies a novel role for DHR96 and 
magro in preventing the accumulation of excess sterols. Animals lacking DHR96 or 
magro function exhibit elevated levels of cholesterol. My data indicate that these defects 
are due, in part, to an inability to break down stored cholesterol esters in the intestine. 
Taken together, my studies describe a mechanism by which nuclear receptors can 
coordinate multiple aspects of lipid homeostasis and demonstrates that a single direct 
target of these receptors can exert distinct key functions in different regions of the 
intestine.  
 Finally, in Chapter 4, I describe a new direction for my research that arose from 
my studies of DHR96 and magro. In the course of this work, I noticed that wild-type flies 
display significant changes in absolute levels of TAG between experiments, and that 
these changes were not always apparent in the DHR96 mutant. A series of studies 
revealed that these changes in TAG levels were not due to nutritional effects on that 
generation of flies, but rather reflected the health and nutrition of their parents. As a 
result, I began investigating the impact of parental diet on the metabolic status of their 
progeny. When parental flies are transiently exposed to a nutrient poor diet, the resulting 
progeny show an ~2-fold increase in whole animal TAG levels. Furthermore, mutants 
lacking DHR96 function are unable to mediate this transgenerational response to parental 
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diet, suggesting that this receptor plays a key role in this pathway. These 
transgenerational effects on metabolic status are likely mediated by epigenetic changes in 
chromatin state. This hypothesis is supported by studies of animals heterozygous for a 
mutation in HP1, which encodes a conserved chromosomal protein that is involved in 
heterochromatin formation. My data support the model that transgerational changes in 
chromatin state adjust the metabolic state of the progeny to provide them with a 
physiological advantage for survival in their nutritional environment.  
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Triacylglycerol (TAG) homeostasis is an integral part
of normal physiology and essential for proper energy
metabolism. Herewe show that the singleDrosophila
ortholog of the PXR and CAR nuclear receptors,
DHR96, plays an essential role in TAG homeostasis.
DHR96 mutants are sensitive to starvation, have
reduced levels of TAG in the fat body and midgut,
and are resistant to diet-induced obesity, while
DHR96 overexpression leads to starvation resis-
tance and increased TAG levels. We show that
DHR96 function is required in the midgut for the
breakdown of dietary fat and that it exerts this effect
through the CG5932 gastric lipase, which is essential
for TAG homeostasis. This study provides insights
into the regulation of dietary fat metabolism in
Drosophila and demonstrates that the regulation of
lipid metabolism is an ancestral function of the
PXR/CAR/DHR96 nuclear receptor subfamily.
INTRODUCTION
Fat metabolism is central to the process of energy homeostasis.
When nutrients are abundant, dietary fat in the form of triacylgly-
cerol (TAG) is broken down by gastric TAG lipases to release
fatty acids. These fatty acids are absorbed by the intestine
and used to resynthesize TAG in peripheral tissues. These
TAG reserves can be accessed upon nutrient deprivation
through the action of specific lipid droplet-associated lipases
that release the fatty acids for energy production through mito-
chondrial fatty acid b-oxidation. Defects in these processes can
lead to dramatic changes in TAG levels and a range of physio-
logical disorders, including obesity, diabetes, and cardiovas-
cular disease. The alarming rise in the prevalence of these disor-
ders in human populations has focused attention on
understanding the molecular mechanisms that coordinate die-
tary nutrient uptake with TAG homeostasis. As a result, many
regulators of TAG metabolism have been identified, including
SREBP, PPAR, and adiponectin. In spite of these advances,
however, the molecular mechanisms that coordinate dietary
fat uptake, synthesis, storage, and utilization remain poorly
understood.
Nuclear receptors (NRs) are ligand-regulated transcription
factors that play a central role in metabolic control. They are
defined by a conserved zinc-finger DNA-binding domain (DBD)
and a C-terminal ligand-binding domain (LBD) that can impart
multiple functions, including hormone binding, receptor dimer-
ization, and transactivation. Many NRs are regulated by small
lipophilic compounds that include dietary signals and metabolic
intermediates, and exert their effects by directing global
changes in gene expression that act to maintain metabolic
homeostasis. This is exemplified by members of the mammalian
PPAR, LXR, and FXR subfamilies, which play critical roles in
adipogenesis, lipid metabolism, and cholesterol and bile acid
homeostasis, respectively (Chawla et al., 2001; Sonoda et al.,
2008).
In this study we use the fruit fly, Drosophila melanogaster, as
a simple model system to characterize the NR subfamily repre-
sented by the Pregnane X Receptor (PXR, NR1I2), Constitutive
Androstane Receptor (CAR, NR1I3), and Vitamin D Receptor
(VDR, NR1I1) in mammals. Previous studies have defined central
roles for these receptors in sensing xenobiotic compounds and
directly regulating genes involved in detoxification (Timsit and
Negishi, 2007; Willson and Kliewer, 2002). Initial studies showed
that the single ancestralDrosophila ortholog of this NR subclass,
DHR96, has similar functions (King-Jones et al., 2006). A DHR96
null mutant displays increased sensitivity to the sedative effects
of phenobarbital and the pesticide DDT as well as defects in the
expression of phenobarbital-regulated genes. These studies,
however, revealed other potential roles for the receptor—in
particular, unexpected effects on the expression of genes that
are predicted to regulate lipid and carbohydrate metabolism
(King-Jones et al., 2006). This observation is in line with recent
studies that have implicated roles for the mammalian PXR and
CAR NRs in metabolic control (Moreau et al., 2008). The molec-
ular mechanism by which they exert this effect, however,
remains undefined.
Here we show thatDHR96 null mutants are sensitive to starva-
tion and have reduced levels of TAG, while DHR96 overexpres-
sion leads to starvation resistance and elevated TAG levels. A
series of studies using metabolic assays, diets, and the drug
Orlistat revealed thatDHR96mutants are defective in their ability
to break down dietary lipid. This model was supported by micro-
array studies, which showed that many genes expressed in the
midgut are misregulated in DHR96 mutants, including highly
reduced expression of the gastric lipase gene CG5932. We
show that CG5932 is required for proper whole-animal TAG
levels, and that selective expression of CG5932 in the midgut
of DHR96 mutants is sufficient to rescue their lean phenotype.
Taken together, these data support a role for the PXR/CAR/
DHR96 NR subclass in lipid metabolism and define DHR96 as
a key regulator of dietary TAG breakdown in the Drosophila
midgut.






DHR96 Mutants Are Lean and Sensitive to Starvation
Previous studies have shown that DHR961 null mutants, grown
under normal conditions, are viable and fertile with no apparent
developmental defects (King-Jones et al., 2006). To assess
potential metabolic roles for DHR96, we examined the ability of
mutants to survive a period of complete starvation. All studies
were performed using Canton-S wild-type flies (CanS) and
DHR961 null mutants that had been crossed to CanS through
nine generations of free recombination. Mature male flies were
collected as 5- to 7-day-old adults, transferred to starvation
media, and the number of living animals scored every 4 hours.
DHR961 mutants die at a faster rate than the wild-type controls
(Figure 1A). We also tested DHR962X animals, which carry two
transgenic copies of DHR96 along with the endogenous wild-
type locus. These flies express approximately 2-fold more
DHR96 protein than wild-type animals (M. Horner, personal
communication). The DHR962X animals are more resistant to
starvation than the wild-type controls (Figure 1A). Taken
together, these opposite effects of DHR96 loss of function and
gain of function on the starvation response suggest that this
factor plays a central role in maintaining energy homeostasis.
As a first step toward determining the basis for these effects
on the starvation response, we measured the major forms of
stored energy in the animal, glycogen and TAG levels, in control,
DHR961, and DHR962X stocks, under both fed conditions and
after 20 hr of starvation. Both the DHR961 mutant and
DHR962X animals have wild-type levels of glycogen under
normal feeding conditions (Figure 1B). The mutant, however,
has significantly less glycogen upon starvation than the wild-
type control. Interestingly, TAG levels are reduced in both fed
and starved DHR961 mutants and are elevated in both fed and
starved DHR962X animals relative to controls (Figure 1C). An
!2-fold reduction in TAG is also seen with a second DHR96
null allele and is effectively rescued by a wild-type genomic
DHR96 transgene (see Figure S1 available online). Taken
together, these observations suggest that the starvation sensi-
tivity of DHR96 mutants is caused by a deficit of stored energy
in the form of TAG, and implicate a central role for DHR96 in
TAG homeostasis.
To confirm and extend these results, we examined the distri-
bution of neutral lipids in the major sites of fat storage in the
animal, the fat body and midgut. Fat body cells were dissected
from 1- to 2-day-old control male flies, DHR961 mutants, and
the DHR962X overexpression strain and stained with Nile red
(Figures 1D–1F). DHR96mutant fat body cells are approximately
half the size of those in controls, with an average !3-fold reduc-
tion in lipid droplet size (Figures S2A and S2B). Conversely, fat
body cells from the DHR962X overexpression strain are wild-
type in size but have lipid droplets that are, on average, nine
times larger than those in control fat cells (Figures S2A and
S2B). Similar results were seen when the midguts of control,
DHR961 mutant, and DHR962X animals were dissected and
stained with oil red O (Figures 1G–1I). Whereas low levels of
neutral lipids can be detected in the gut epithelium of control
flies (Figure 1G), no staining is evident in the gut epithelium of
DHR961mutants (Figure 1H), and large lipid droplets are present
in the midguts of DHR962X animals (Figure 1I). These results
support our measurements of whole-animal TAG levels and indi-
cate that DHR96 plays a central role in the process of lipid
metabolism.
DHR96 Mutants Are Resistant to Diet-Induced Obesity
We next tested whether dietary conditions can alter the TAG
levels in DHR96mutant flies. Control CanS andDHR961mutants
Figure 1. DHR96 Mutants Are Sensitive to
Starvation and Display Decreased Levels
of TAG
(A) Mature adult male Canton-S (CanS) control
flies, DHR961 mutants, and the DHR962X overex-
pression strain were subjected to complete star-
vation, and the number of surviving animals was
determined at 4 hr intervals. Results are presented
as a percent of the total population, which con-
sisted of 15 groups of 20 animals for each geno-
type. Similar results were obtained in a second
independent experiment as well as from adult flies
staged at 1–2 days after eclosion.
(B and C) Total glycogen (B) and TAG (C) levels
were measured in CanS control flies, DHR961
mutants, and the DHR962X overexpression strain
under both fed conditions and after a 20 hr starva-
tion. Glycogen and TAG levels were normalized for
total protein and are presented as normalized to
a wild-type level of 100%.
(D–F) Nile red staining of dissected fat body cells
from 1- to 2-day-old adult male flies shows
reduced cell size and lipid droplet size in DHR961
mutants (E) and increased lipid droplet size in
DHR962X animals (F), relative to CanS controls (D).
(G–I) Oil red O staining of dissected adult midguts shows reduced lipid accumulation in the DHR961 mutant (H) and enlarged lipid droplets in the DHR962X over-
expression strain (I), relative toCanS controls (G). The white brackets mark comparable regions of the midgut epithelium. The lumen of the midgut can be seen in
the DHR961 mutant (arrow). Scale bars are 75 mm (D–F) or 400 mm (G–I). Error bars represent ±SE, *p < 0.05 and **p < 0.001.
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were transferred to a previously characterized low-calorie
(0.5 SY) or high-calorie (2.0 SY) medium and assayed for specific
changes in TAG levels after 1 week (Mair et al., 2005). Control
flies maintained on the high-calorie diet display a significant
increase in whole-animal TAG levels relative to that seen in flies
maintained on the low calorie diet (Figure 2A). Interestingly,
DHR96 mutants grown on either the low-calorie or high-calorie
media display a lean phenotype relative to control animals on
the restrictive diet. These observations support the proposal
that DHR96 mutants are genetically lean and indicate that they
are resistant to diet-induced obesity.
It is possible that a reduced feeding rate could contribute to
the lean phenotype in DHR96 mutants. To test this possibility,
both control and DHR961 mutant flies were transferred to
medium supplemented with a radioactive dCTP tracer, and the
amount of retained label was measured after a 12 hr period (Car-
valho et al., 2005). DHR96 mutants display a mild (12%–18%)
decrease in the amount of ingested food relative to the controls
(Figure 2B). No change in food content, however, was seen upon
spectrophotometric measurement of extracts from flies grown
on yeast paste supplemented with 0.05% Bromophenol blue
(data not shown). Based on these assays, we conclude that
a reduction in feeding rate is unlikely to be a major cause of
the lean phenotype in DHR96 mutants. Similarly, there is no
significant change in the amount of radiolabeled oleic acid re-
tained inDHR96mutants after a 12 hr feeding period, suggesting
that they have no major defects in dietary fatty acid uptake
(Figure 2C).
DHR96 Mutants Are Resistant to Orlistat Treatment
We next wanted to determine if dietary TAG breakdown contrib-
utes to the lean phenotype in DHR96 mutants. As a first step
toward this goal, TAG levels were measured in control and
DHR961 mutants that were maintained for 5 days on media sup-
plemented with 2 mM Orlistat (Figure 3A). Orlistat (tetrahydrolip-
statin) is a widely used over-the-counter weight loss drug (Heck
et al., 2000). It acts inside the intestine as a competitive inhibitor
of pancreatic and gastric lipases, preventing their interaction
with dietary TAG and thus blocking fatty acid release and dietary
lipid uptake. Control flies exposed to Orlistat display a significant
reduction in fat levels (Figure 3A). A similar effect was seen in
mutants for the fly perilipin homolog Lsd-2, which are lean due
to reduced levels of fat body TAG, consistent with the conclusion
that Orlistat specifically inhibits Drosophila gastric lipases
(Gro¨nke et al., 2003) (Figure S3A). In contrast, no effect was
seen upon exposing DHR96 mutants to the drug. These obser-
vations were confirmed by staining midguts dissected from
either untreated or Orlistat-treated control and DHR961 mutants
Figure 2. DHR96 Mutants Are Resistant to
Diet-Induced Obesity
(A) Mature adult male Canton-S (CanS) control
flies andDHR961mutants were subjected to either
a low-calorie 0.5 SY or high-calorie 2.0 SY diet for
7 days, after which TAG levels were determined.
TAG levels were normalized for total protein and
are presented as normalized to a wild-type level
of 100%.
(B) Food uptake is slightly reduced in DHR96
mutants, as determined by scintillation counting
of Canton-S (CanS) control flies and DHR961
mutants that were maintained on food supple-
mented with 32P-dCTP.
(C) DHR96 mutants can efficiently absorb dietary
fatty acids, as determined by scintillation counting of Canton-S (CanS) control flies and DHR961 mutants that were maintained on food supplemented with
3H-oleic acid (p = 0.18).
Error bars represent ±SE, *p < 0.05 and ***p < 0.0001.
Figure 3. DHR96 Mutants Are Resistant to
Treatment with Orlistat
(A) Mature adult male Canton-S (CanS) control
flies and DHR961 mutants were transferred to
a diet either with or without 2.0 mM Orlistat for
5–7 days, after which TAG levels were determined.
TAG levels were normalized for total protein and
are presented as normalized to a wild-type level
of 100%. Error bars represent ±SE, ***p < 0.0001.
(B–E) Oil red O staining of dissected adult midguts
shows that lipid accumulation is significantly
reduced in CanS flies fed Orlistat (C), relative to
controls (B) and undetectable in DHR961 mutants
maintained on either normal food (D) or food sup-
plemented with Orlistat (E). Low levels of lipids can
be detected in the midgut lumen of DHR96
mutants and CanS flies fed Orlistat (arrows). Scale
bars are 400 mm.
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with oil red O (Figures 3B–3E). Control flies maintained on the
high-nutrient diet used for this study display clearly detectable
levels of neutral lipids in their gut epithelium, and this level is
significantly reduced in the midguts of animals exposed to Orli-
stat (Figures 3B and 3C). In contrast, DHR96 mutants display
no detectable neutral lipids in their midguts, either in the pres-
ence or the absence of drug (Figures 3D and 3E). These results
raise the possibility that the lean phenotype in DHR96 mutants
may arise, at least in part, from decreased TAG lipase activity
in the midgut.
DHR96 Functions in the Midgut to Control the
Breakdown of Dietary TAG
To test the possibility that DHR96 mutants have a decreased
ability to break down dietary fat, lysates were prepared from
dissected control CanS and DHR961 mutant midguts and as-
sayed for TAG lipase activity by examining their ability to cleave
a glycerol tributyrate substrate. This experiment showed that
lysates from DHR96 mutants have significantly reduced lipase
activity relative to lysates from control animals, suggesting that
decreased gastric lipase activity is a primary cause of the lean
phenotype in DHR96 mutants (Figure 4A). To further test this
model, we attempted to bypass the need for midgut lipolysis
by rescuing the lean phenotype through dietary supplementation
with free fatty acids. ControlCanS andDHR961mutant flies were
transferred to a lipid-depleted medium that was either unsupple-
mented with lipid or supplemented with a mixture of stearic acid
and oleic acid (free fatty acids) or a mixture of glycerol tristearate
and glycerol trioleate (TAG). Extracts were prepared from these
animals after 7 days and assayed for TAG levels (Figure 4B).
As expected, DHR96 mutants maintained on the lipid-depleted
medium continue to display the lean phenotype. Interestingly,
the same phenotype is seen when DHR96 mutants are main-
tained in the presence of supplemented TAG, while the lean
phenotype is effectively rescued by dietary supplementation
with free fatty acids (Figure 4B). This observation indicates that
an inability to break down dietary TAG is a major contributing
factor to the lean phenotype seen in DHR96 mutants. Phospho-
lipid digestion, however, appears to be normal in DHR96
mutants, as revealed by cleavage of the quenched fluorescent
phospholipid PED6, which provides an accurate indicator of
gastric phospholipase activity (data not shown) (Farber et al.,
2001).
Expression of wild-type DHR96 effectively rescues the lean
phenotype of DHR96 mutants, indicating that this phenotype
can be attributed to a specific defect in DHR96 function
(Figure S1). If, however, DHR96 regulates the breakdown of die-
tary fat, then we should be able to rescue themutant lean pheno-
type by specifically expressing the wild-type receptor in the
midgut of DHR96 mutants. Consistent with this proposal,
specific expression of wild-type DHR96 in the fat body of
DHR96 mutants does not have a significant effect on the low
levels of TAG seen in these animals, while specific expression
of wild-type DHR96 in the midgut of DHR96 mutants effectively
rescues the lean phenotype (Figure 4C). This observation indi-
cates that the reduced levels of TAG seen in DHR96 mutants
arise from defects in midgut function. Taken together with our
dietary rescue experiments, we conclude that DHR96 plays
a central role in controlling the breakdown of dietary fat.
DHR96 Regulates Genes Expressed in the Midgut and
Involved in Metabolism
Microarray studies were conducted to determine the molecular
mechanisms by which DHR96 regulates lipid homeostasis.
Figure 4. DHR96 Functions in the Midgut to Control Dietary TAG
Breakdown
(A) Midguts dissected from mature adult male Canton-S (CanS) control flies
and DHR961 mutants were homogenized, and increasing amounts of lysate
were tested for TAG lipolytic activity by assaying for the release of glycerol
from a glycerol tributyrate emulsion.
(B) Mature adult maleCanton-S (CanS) control flies andDHR961mutants were
transferred to lipid extracted 1.0 SY medium alone (!lipid), medium supple-
mented with TAG (+TAG), or medium supplemented with free fatty acids
(+FFA) for 7 days, after which TAG levels were determined. TAG levels were
normalized for total protein and are presented as normalized to a level of
100% in CanS flies on the unsupplemented lipid-extracted medium.
(C) Tissue-specific expression of a wild-type UAS-DHR96 transgene in the
midgut of DHR96 mutants, driven by Mex-GAL4 (Mex > DHR96), is sufficient
to rescue the lean phenotype. In contrast, little effect is seen when Cg-GAL4
is used to drive fat body-specific expression of the UAS-DHR96 transgene
(Cg > DHR96). The presence of the GAL4 drivers alone or the UAS-DHR96
transgene in the DHR96 mutant background has no effect on TAG levels
(data not shown). Error bars represent ±SE, ***p < 0.0001.
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This study revealed that 136 genes are significantly affected by
the DHR96 mutation in fed adult flies, with 94 genes displaying
increased levels of expression and 42 genes showing decreased
levels of expression (Table S1). A significant number of genes
involved in cuticular structure and the peritrophic matrix, which
acts as protective layer inside the lumen of the midgut, are upre-
gulated in the mutant, while many genes that encode predicted
a-mannosidases and endopeptidases are expressed at lower
levels. Genesmore directly involved inmetabolism are also over-
represented in the list of DHR96-regulated genes. These include
two genes that encode larval serum proteins: Lsp1g (+2.2-fold in
the DHR96 mutant) and Lsp2 (+3.1-fold). These proteins are
synthesized by the fat body and are thought to provide a source
of amino acids to support adult development during metamor-
phosis (Telfer and Kunkel, 1991). Interestingly, the gene that
encodes the larval serum protein receptor, Fbp1 (+3.1-fold), is
also regulated by DHR96, suggesting a central role for DHR96
in LSP function (Burmester et al., 1999).Mdr50, which is reduced
in its expression inDHR96mutants (!1.5-fold), is the fly ortholog
of mammalian ATP-binding cassette subfamily B, member 4
(ABCB4), a protein that is primarily expressed in the liver and
involved in phospholipid transport. Similarly, the fifth most
downregulated gene in DHR96 mutants, CG13325, encodes
a protein with a predicted acyltransferase domain that could
function in lipid transport. Finally, it is remarkable that the most
significantly affected genes in DHR96 mutants include most of
the Drosophila orthologs of the Niemann-Pick (NPC) disease
genes that play central roles in cholesterol metabolism, including
npc1b (+2.6-fold up) and five NPC2 family members: npc2c
(+1.7-fold); npc2d (!13-fold); npc2e (+21-fold); and two genes
that are below our 1.5-fold cutoff in expression level, npc2g
and npc2h (both !1.4-fold).
Closer examination of the DHR96-regulated genes reveals
that many are expressed exclusively, or most abundantly, in
the midgut. Of the 132 genes that are misregulated in DHR96
mutants, 42 are included in the 2695midgut-specific genes iden-
tified by Li et al. (2008) (32%; p value = 93 10!9). A similar over-
representation of midgut-expressed genes can be seen by
surveying the expression patterns on FlyAtlas (Chintapalli
et al., 2007). For example, 12 of the 15 most downregulated
genes, and 9 of the 15 most upregulated genes in DHR96
mutants, are highly expressed in the midgut (Figure S4).
Finally, we found that many of theDHR96-regulated genes are
located next to one another in the genome. The gene clusters
include three genes with predicted a-mannosidase activity,
CG9463 (!3.3-fold), CG9466 (!5.9-fold), and CG9468 (!4.3-
fold), all of which are among the most highly downregulated
genes in the mutant. A divergently transcribed pair of genes
with predicted a-mannosidase activity are also misregulated in
DHR96 mutants, CG5322 (!1.3-fold) and CG6206 (!1.8-fold),
as well as two genes with predicted a-glucosidase activity,
CG14934 (+1.5-fold) and CG14935 (!1.6-fold), and a cluster of
two Jonah genes that encode predicted gastric peptidases,
Jon65Ai and Jon65Aii (both !1.7-fold). Two genes with pre-
dicted sphingomyelin phosphodiesterase activity, CG15533
(+2.0-fold) and CG15534 (+1.3-fold), are regulated by DHR96.
Moreover, many of the NPC genes that are misregulated in
DHR96 mutants lie within gene clusters. These include npc2d
(!13-fold), npc2e (+21-fold), and npc2c (+1.7-fold). An adjacent
gene, fancl, which has no known function, is downregulated 1.5-
fold inDHR96mutants. In addition, npc2g and npc2h are located
next to one another in the genome.
DHR96 Regulates the CG5932 Gastric Lipase to
Promote TAG Accumulation
Two genes that encode predicted TAG lipases were identified in
our microarray study of DHR96mutants, CG5932 and CG31091
(Table S1). Both genes encode members of the a/b-hydrolase
fold lipase family and are homologs of human gastric lipases,
with 37% and 33% amino acid identity, respectively. In addition,
both genes are expressed almost exclusively in the larval and
adult midgut (Chintapalli et al., 2007), raising the possibility that
their misexpression may contribute to the reduced ability of
DHR96 mutants to break down dietary TAG. Validation of the
effects of theDHR96mutation onCG5932 andCG31091 expres-
sion by northern blot hybridization showed that CG31091mRNA
levels are very low, consistent with the CG31091 expression
levels reported on FlyAtlas (Chintapalli et al., 2007) (data not
shown). In contrast, CG5932 is abundantly expressed and is
downregulated by starvation in wild-type flies (Figure 5A, lanes
1 and 3), and this expression is significantly reduced in fed or
starved DHR96 mutants (Figure 5A, lanes 2 and 4). CG5932 is
also the fourth most highly downregulated gene identified in
our microarray study. Chromatin immunoprecipitation of
DHR96 protein from wild-type lysates revealed direct binding
to sequences immediately upstream from CG5932 (Figure S5).
This binding is not seen at a promoter that is independent of
DHR96 regulation or in chromatin immunoprecipitation experi-
ments using lysates made from DHR96 mutants, suggesting
that it represents a specific DNA-protein interaction. Moreover,
expression of wild-type DHR96 in the midgut of DHR96mutants
is sufficient to restore normal CG5932 expression (data not
shown). Taken together, these observations suggest that
DHR96 maintains TAG homeostasis through direct regulation
of CG5932 expression.
If CG5932 is essential for TAG homeostasis, then disruption of
CG5932 function should lead to changes in TAG levels. To test
this possibility, we used Act-GAL4 to drive the expression of
a UAS-CG5932 RNAi construct. Whereas flies that carry either
the Act-GAL4 driver alone or the UAS-CG5932 RNAi construct
alone display normal levels of TAG and CG5932 expression,
combining Act-GAL4 with the UAS-CG5932 RNAi construct re-
sulted in significant reduction of both whole-animal TAG levels
and CG5932 mRNA accumulation (Figure 5B). Similar results
were seen upon driving UAS-CG5932 RNAi with the midgut-
specific Mex-GAL4 driver (Figure S6A). These animals are also
sensitive to starvation, consistent with their lean phenotype
(Figure S6B). In addition, purified CG5932 protein has lipolytic
activity in vitro, as demonstrated by its ability to break down
a glycerol tributyrate substrate (Figure S7). Taken together, these
observations indicate that CG5932 plays a critical role in the
midgut to regulate whole-animal TAG homeostasis, most likely
through its effect on the breakdown of dietary fat.
If the downregulation of CG5932 expression in DHR96
mutants contributes to their inability to break down dietary
TAG, then restoring CG5932 expression specifically in the
midgut of these animals should rescue their lean phenotype.
To test this possibility, we established transformant lines that
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carry two different insertions of a UAS-CG5932 transgene. As
expected, the presence of either the midgut-specific Mex-Gal4
driver alone or each UAS-CG5932 transgene had little or no
effect on the reduced TAG levels seen in the DHR96 mutant
(Figure 6). Combining the Mex-GAL4 driver with either of the
UAS-CG5932 transgenes in a DHR96 mutant, however, allows
themutant to recover normal levels of TAG (Figure 6). In addition,
overexpression of CG5932 does not stimulate an increase in
whole-animal TAG levels, indicating that while CG5932 is neces-
sary for TAG homeostasis, it is not sufficient to drive TAG accu-
mulation (Figure S8). These results, combined with our observa-
tion that the lean phenotype in DHR96 mutants can be rescued
by dietary supplementation with free fatty acids (Figure 4B),
and the absence of an effect of Orlistat treatment in DHR96
mutants (Figure 3A) or Act > CG5932 RNAi animals (Figure S3B),
suggests that DHR96 controls whole-animal TAG levels through
its regulation of the CG5932 gastric lipase.
DISCUSSION
Recent studies have implicated roles for mammalian PXR and
CAR in controlling lipid metabolism, although little is known
regarding the molecular mechanisms by which they exert these
effects. Here we show that the singleDrosophila ortholog of PXR
and CAR, DHR96, plays an essential role in maintaining whole-
animal TAG levels through the proper breakdown of dietary fat.
Our results indicate that DHR96 acts through a previously un-
characterized gastric lipase encoded by CG5932 to promote
dietary lipid uptake and maintain TAG homeostasis.
DHR96 Mutants Are Sensitive to Starvation
Due to Decreased Levels of TAG
Although DHR96 null mutants are viable and fertile, with no
morphological defects, they die significantly more rapidly than
genetically matched control flies under starvation conditions,
while DHR96 overexpression leads to starvation resistance
(Figure 1A). The effects of these genotypes on the major forms
of stored energy in the animal, glycogen and TAG, are consistent
with their effects on the starvation response. DHR96 mutants
have reduced levels of TAG under both fed and starved condi-
tions, while DHR96 overexpression leads to increased TAG
levels (Figure 1C). Although no effects are seen on whole-animal
glycogen levels in fed animals that either lack or overexpress
DHR96, the mutants consume significantly more glycogen
upon starvation than do controls (Figure 1B). This rapid utilization
of glycogen stores is most likely due to the decreased energy
contribution from TAG. Taken together, these observations
suggest that the starvation sensitivity of DHR96 mutants can
be attributed to their lean phenotype, while the starvation resis-
tance of the DHR962X strain is due to their excess energy in the
form of TAG. This proposal is supported by the observation that
genetically elevating the levels of TAG in DHR96 mutants by
introducing mutations in bmm or AKHR, which control distinct
aspects of fat body TAG lipolysis (Gro¨nke et al., 2007), effectively
Figure 6. Midgut-Specific Expression of CG5932 Rescues the Lean
Phenotype of DHR96 Mutants
TAG levels were determined inmature adult maleCanton-S (CanS) control flies
or DHR961 mutants that carried different transgenes. Either the midgut-
specific Mex-GAL4 driver alone or two different insertions of the UAS-
CG5932 rescue transgene alone (UAS-CG59321 or UAS-CG59322) had little
or no effect on whole-animal TAG levels. The increased level of TAG seen in
the presence of UAS-CG59322 alone could be due to background expression
from a flanking regulatory element, as is often seen with P element insertions.
In contrast, combining the Mex-GAL4 driver with each UAS-CG5932 rescue
transgene restored normal TAG levels. TAG levels were normalized for total
protein and are presented as normalized to a wild-type level of 100%. Error
bars represent ±SE, **p < 0.001 and ***p < 0.0001.
Figure 5. DHR96 Regulates the CG5932 Gastric Lipase Gene to
Control the Breakdown of Dietary TAG
(A) RNA was isolated from either fed or starved CanS control flies (+ DHR96)
and DHR961 mutants (! DHR96) and analyzed by northern blot hybridization
for CG5932 transcription. Hybridization to detect rp49 mRNA was used as
a control for loading and transfer.
(B) An Act-GAL4 driver or the UAS-CG5932 RNAi transgene alone have no
effect on whole-animal TAG levels (above) or CG5932 mRNA levels (below),
as determinedbynorthern blot hybridization.Combining these two transgenes,
however, effectively reduces CG5932 expression and leads to a significant
reduction in total TAG levels. Hybridization to detect rp49 mRNA was used
as a control for loading and transfer. Error bars represent ±SE, ***p < 0.0001.
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rescues their starvation sensitivity (Figure S9). In addition, the
opposite effects of DHR96 loss of function and gain of function
on both the starvation response and TAG levels argue that this
receptor plays a central role in maintaining whole-animal TAG
homeostasis.
DHR96 Functions in the Midgut to Regulate the Uptake
of Dietary Nutrients
Several lines of evidence support the conclusion that DHR96
exerts its primary metabolic functions through themidgut. These
include our initial observation that DHR96 mutants are resistant
to treatment with the gastric lipase inhibitor Orlistat (Figure 3)
and display reduced levels of midgut lipolytic activity
(Figure 4A). In addition, dietary supplementation with free fatty
acids, but not TAG, is sufficient to rescue the lean phenotype
of DHR96 mutants, as is midgut-specific expression of wild-
type DHR96 in a DHR96 mutant background (Figure 4C). We
also see a dramatic effect on lipid levels in the midgut, where
almost no neutral lipids are detectable in DHR96 mutants and
enlarged lipid droplets are evident in DHR962X flies maintained
on a normal diet (Figures 1H and 1I). Interestingly, while the
lumen of the midgut is not evident in control animals, we clearly
see material in the lumen of DHR96mutant midguts or in control
flies that are treated with Orlistat (Figures 1H and 3C–3E). In
some cases, this material is stained by oil red O, suggesting
that it may represent an increased level of undigested fat in these
animals. This phenotype would be similar to that seen in humans
who have defects in intestinal lipase activity (Ligumsky et al.,
1990). Likewise, an increase in the passage of undigested dietary
fat is a complication associated with Orlistat treatment in
patients (Heck et al., 2000). Taken together, these observations
support the conclusion thatDHR96 acts in themidgut to regulate
the breakdown of dietary fat.
An essential role for DHR96 in the midgut is further supported
by our microarray study, which revealed that manyDHR96-regu-
lated genes are primarily expressed in this tissue. Interestingly,
many of these genes have predicted roles related to the break-
down of dietary nutrients (Table S1). These include downregula-
tion of multiple genes with predicted a-mannosidase activity,
which is involved in the breakdown of the complex sugars found
on glycoproteins. Many genes that encode trypsins and endo-
peptidases are also expressed at reduced levels in DHR96
mutants as well as a few genes that encode predicted a-gluco-
sidases, which are involved in the breakdown of dietary carbohy-
drates. In addition, a number of genes involved in the formation
of the peritrophic matrix are more abundantly expressed in
DHR96 mutants. This matrix is comprised of chitin and peritro-
phic proteins and acts as a protective layer for the epithelial
surface of the midgut (Hegedus et al., 2009). The peritrophic
matrix also has critical roles in facilitating digestion. Only smaller
molecules that arise from the initial digestion of complex nutri-
ents, including peptides, sugars, and lipids, can move through
the peritrophic matrix for final digestion and absorption by the
midgut epithelium. These events are controlled by the selective
partitioning of digestive enzymes to different sides of the peritro-
phic matrix as well as within the matrix itself. Thus, while midgut
morphology appears normal in DHR96mutants, the effect of the
mutation on the peritrophic matrix could impact nutrient diges-
tion and absorption.
In addition to genes that regulate different aspects of lipid
metabolism, our microarray study of DHR96 mutants identified
widespread effects on the expression of Drosophila homologs
of NPC disease genes. The npc1b gene, which encodes an
essential cholesterol transporter and the ortholog of mammalian
NPC1L1 (Voght et al., 2007), is the tenth most highly upregulated
gene in DHR96 mutants. In addition, five of the eight Drosophila
NPC2 genes are misregulated inDHR96mutants: npc2c, npc2d,
npc2e, npc2g, and npc2h (Huang et al., 2007). These genes
encode homologs of mammalian NPC2, which is involved in
intracellular cholesterol trafficking (Huang et al., 2007). Remark-
ably, two of these genes are the most highly up- and downregu-
lated genes identified in the mutant (npc2e and npc2d, respec-
tively; Table S1). Moreover, many of these npc genes are
located in clusters, suggesting that they are coregulated by the
receptor. Although the function of these npc2 genes is unknown,
their disproportionate representation within the list of DHR96-
regulated genes implies a critical role for the receptor in regu-
lating cholesterol trafficking. Indeed, dietary cholesterol triggers
a widespread transcriptional response in Drosophila that is
dependent on DHR96 function (Horner et al., 2009). Moreover,
this study showed that DHR96 mutants display defects in their
ability to maintain cholesterol homeostasis when grown on
a high-cholesterol diet. Taken together with the results pre-
sented here, our studies suggest that DHR96 plays an essential
role in the midgut to coordinate the processes of TAG and
cholesterol breakdown, absorption, and trafficking.
DHR96 Regulates CG5932 to Control the Breakdown
of Dietary TAG
Two genes with predicted TAG lipase activity are expressed at
lower levels in DHR96 mutants (Table S1). One of these genes,
CG5932, is abundantly expressed in the larval and adult midgut,
encodes a protein that is highly related to human gastric lipase
(LIPF, 37% identity over 358 amino acids), and is essential for
maintaining whole-animal TAG levels (Figure 5). In addition,
restoring CG5932 expression in the midguts of DHR96 mutants
is sufficient to rescue their lean phenotype, defining this gene
as a critical functional target of the receptor (Figure 6). Interest-
ingly, CG5932 expression is also regulated by starvation, with
reduced expression in the absence of food and increased
expression upon refeeding (Figure 5A) (Gershman et al., 2006).
This regulation is consistent with an essential role for CG5932
in the breakdown of dietary fat, where its expression is upregu-
lated when food is present. This response, however, is unaf-
fected in DHR96mutants, indicating that it is under independent
control, possibly by known regulators of the starvation response
such as dFOXO (Gershman et al., 2006).
The identification of CG5932 as a key functional target of
DHR96 raises the question of how that regulation is achieved.
We have tested a range of dietary parameters and candidate
ligands using the GAL4-DHR96 ligand sensor but have been
unable to identify conditions that activate the DHR96 LBD (Pal-
anker et al., 2006). In addition, the DHR96-binding site remains
undefined. DHR96 has a unique P box sequence within its
DBD, which determines its DNA-binding specificity. This
sequence is only shared by three C. elegans NRs, DAF-12,
NHR-48, and NHR-8. Consistent with this observation, we found
that DHR96 protein fails to bind to most canonical NR-binding
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sites, except for weak binding to a palindromic EcR response
element (Fisk and Thummel, 1995). One study has shown that
DAF-12 displays preferential binding to a direct repeat of two
distinct hexanucleotide sequences (AGGACA and AGTGCA),
separated by five nucleotides (DR5) (Shostak et al., 2004).
Whether DAF-12 contacts these sequences as a homodimer or
a heterodimer with another NR, however, remains to be deter-
mined. The observation that many DHR96-regulated genes are
arranged in clusters and DHR96 binds directly to a region
upstream from the CG5932 start site provides an ideal context
for defining its DNA-binding specificity as well as determining
the molecular mechanisms by which DHR96 coordinates target
gene transcription.
DHR96 May Indirectly Regulate Xenobiotic Responses
in Drosophila
Our studies of DHR96 raise the interesting possibility that the
defects in xenobiotic detoxification seen in DHR96 mutants
may arise, at least in part, from its role in regulating midgut meta-
bolic activity. As noted in our original study, most of the genes
that are regulated by phenobarbital in wild-type flies do so inde-
pendently of DHR96 (King-Jones et al., 2006). These genes
include representatives of the major classes associated with
xenobiotic detoxification: cytochrome P450 monooxygenases
(P450s), glutathione S-transferases (GSTs), carboxylesterases,
and UDP-glucuronosyl transferases (UGTs). Moreover, some
phenobarbital-regulated genes that are misregulated in DHR96
mutants still show a transcriptional response to the drug,
although that response is muted. These observations indicate
that one or more other factors contribute to the transcriptional
response to xenobiotic challenge in Drosophila. Interestingly,
similar results have been observed in vertebrates, where less
then half of the genes that are regulated by xenobiotics are
affected in PXR and CAR mutant mice (Maglich et al., 2002;
Ueda et al., 2002). It remains unclear, however, whether this
lack of regulation might be due to functional redundancy
between these mammalian receptors.
There are several possible mechanisms by which the meta-
bolic functions of DHR96 could impact xenobiotic responses.
First, a recent study of the expression patterns of Drosophila
P450 genes showed that 34 of 60 genes that could be detected
in third-instar larvae are expressed in the midgut or hindgut
(Chung et al., 2009). A similar overrepresentation of P450 genes
is evident in a microarray study of midgut expressed genes
(Li et al., 2008). These observations indicate that, contrary to
previous assumptions, the gut, and not the fat body, may be
a critical site for xenobiotic detoxification (Chung et al., 2009).
If this is true, then the sensitivity of DHR96mutants to phenobar-
bital or DDT treatment may be affected by the effects of this
mutation on midgut physiology. This could occur through
defects in the peritrophic matrix or through changes in the ability
of themidgut to absorb lipophilic xenobiotic compounds such as
DDT. An alternative possibility is that the sensitivity of DHR96
mutants to xenobiotics might be due to their decreased energy
stores. Detoxification requires energy expenditure. For example,
P450s consume NADPH or NADH for their oxidation of xenobi-
otics, UGTs consume glucose, and GSTs consume glutathione.
Thus, the reduced levels of stored energy in DHR96 mutants
might compromise their ability to properly inactivate toxic
compounds. In addition, the reduced lipid stores in DHR96
mutants might exert an indirect effect on xenobiotic responses
by lowering the ability of the animal to sequester toxins in the
fat reserves of the animal. Thus, there are multiple pathways
by which the midgut-specific metabolic defects associated
with the DHR96 mutation might indirectly affect xenobiotic
responses in these animals. Further studies are required to test
this possibility and clarify the functional overlaps between the
roles ofDHR96 in lipidmetabolism and xenobiotic detoxification.
Conserved Roles for the PXR/CAR/DHR96 Nuclear
Receptors in Lipid Metabolism
Several recent studies have demonstrated roles for both PXR
and CAR in lipid metabolism (Moreau et al., 2008). CAR can
repress the transcription of genes encoding carnitine palmitoyl-
transferase and enoyl-CoA isomerase, key steps in lipid b-oxida-
tion (Ueda et al., 2002). CAR mutant mice are also sensitive to
starvation, much as we observe for DHR96 mutants, and lose
weight more rapidly than wild-type mice when maintained on
a low-calorie diet (Maglich et al., 2004). Transgenic expression
of a constitutively active form of PXR in the mouse liver leads
to hepatic steatosis along with reduced expression of lipid cata-
bolic genes and increased expression of genes involved in lipid
synthesis (Zhou et al., 2006). Importantly, similar effects were
observed upon pharmacological activation of PXR using
a specific agonist, indicating that the endogenous receptor can
contribute to lipid homeostasis (Hoekstra et al., 2009; Nakamura
et al., 2007). Most recently, amutation inCAR has been shown to
normalize the elevated serum TAG levels seen in leptin-deficient
mice or in wild-type mice maintained on a high-fat diet (Maglich
et al., 2009). Conversely, treatment of wild-type mice with
a selective CAR agonist leads to increased serum TAG levels,
and this response fails to occur in a CAR mutant background.
Taken together, these studies indicate that activation of
PXR/CAR receptors leads to lipid accumulation while a loss of
PXR/CAR activity leads to reduced lipid levels, defining a central
role for these NRs in lipid homeostasis. Their role in normal lipid
metabolism, however, remains unknown, although it may be
masked by functional redundancy between the two receptors.
Similarly, the molecular mechanisms by which PXR and CAR
can modulate lipid levels remain to be defined.
Our genetic studies of DHR96 demonstrate that these meta-
bolic activities of PXR and CAR have been conserved through
evolution, and represent an essential ancestral function for this
NR subfamily. Moreover, the observation that DHR96 overex-
pression leads to lipid accumulation and DHR96 mutants are
lean suggests that themolecular mechanisms that underlie these
effects are also conserved across species. This conclusion is
supported by genetic studies of the C. elegans member of this
subfamily, DAF-12, which indicate that this receptor is also
required for proper levels of stored fat (Gerisch et al., 2001).
Our study provides further evidence of a role for this NR
subfamily in normal lipid homeostasis and defines the control
of dietary fat breakdown as a key step at which this regulation
is achieved. In addition, this work provides a foundation for
understanding how dietary lipid uptake can impact normal lipid
metabolism inDrosophila and provides a genetic model for char-
acterizing how dietary factors can lead to lipid metabolic disor-
ders such as obesity.
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The following stocks were used in this study:DHR961 (King-Jones et al., 2006),
Cg-Gal4 (Hennig et al., 2006), Mex-Gal4 (Phillips and Thomas, 2006), Act-
Gal4/CyO (Bloomington # 25374), bmm1 (Gro¨nke et al., 2005), AKHR2 (Gro¨nke
et al., 2007), Lsd-2KG00149 (Gro¨nke et al., 2003), w1118, DHR962X (M. Horner,
personal communication), UAS-DHR96 (M. Horner, personal communication),
and UAS-CG5932 RNAi (National Institute of Genetics stock 5932R-3). Flies
were maintained on standard Bloomington Stock Center medium with malt
at 25!C. The UAS-CG5932 P element construct was made using oligonucleo-
tide primers 50-ATAGAATTCATGAATCCAATCTTCTGCGC-30 and 50- ATACTC
GAGCTAGCGACCTTCGTAGGAGT-30 to amplify the CG5932 cDNA (Gen-
Bank NM_140972) from the DGRC LP10120 cDNA clone by PCR. Following
digestion with EcoRI and XhoI, the cDNA was inserted into the corresponding
sites of the pUAST vector. This UAS-CG5932 construct was then integrated
into the w1118 genome.
Metabolic Assays
All studies used 1- to 2-day-old adult male flies that were aged 5–7 days prior
to the experiment. Starvation sensitivity assays were conducted by transfer-
ring 15 samples of 20 flies of each genotype into vials containing 1% agar.
Mortality was assayed every 4 hr as determined by a lack of responsiveness
to touch. For glycogen and TAG assays, five to ten mature adult male flies
were homogenized in 100–200 ml PBST (PBS, 0.1% Tween 20), heated at
70!C for 5 min to inactivate endogenous enzymes, and the homogenate
cleared by centrifugation for 3 min. The supernatant was diluted 1:4 with
PBST and assayed for glycogen levels as described (Palanker et al., 2009).
TAG assays were conducted as described (Palanker et al., 2009), using the
Stanbio triglyceride liquicolor kit (2100-430). The glycogen and TAG levels in
each sample were normalized for total protein as determined by a Bradford
assay. Both glycogen and TAG data were compiled from six samples collected
from each genotype under each condition. All data are presented as normal-
ized to a wild-type level of 100%. All assays were repeated three times, and
a representative experiment is presented in each figure. Nile red staining
was performed as described by Gro¨nke et al. (2005), using Nile red mounting
media (20% glycerol in PBS, with a 1:10,000 dilution of 10%Nile red in DMSO)
and imaged on a Leica TCS SP2 confocal microscope using an excitation
wavelength of 543 nm and a 600–650 nm emission spectrum. For oil red
O stains, midguts frommature adult flies were dissected and fixed in 4% para-
formaldehyde/PBS for 20 min. The midguts were washed with distilled water
and incubated in 100% propylene glycol for 5 min. Specimens were then incu-
bated at 60!C in oil red O stain (0.5% oil red O in propylene glycol), washed
twice with propylene glycol, washed three times with PBS, and mounted in
20% glycerol/PBS for imaging.
Dietary Treatments
All studies used 1- to 2-day-old adult male flies that were aged 5–7 days prior
to the experiment. Diet-induced obesity was assayed by transferring flies to
either a low-calorie 0.5 SY diet or a high-calorie 2.0 SY diet for 7 days, after
which extracts were prepared and assayed for TAG and protein (Mair et al.,
2005). Food intake was measured by transferring flies to Bloomington corn-
meal, yeast, and molasses medium supplemented with 0.1 mC/ml 32P-dCTP
(Perkin-Elmer) for 12 hr, after which they were transferred to normal unlabeled
food for 4 hr to remove label that was nonspecifically bound to the outside of
the animal (Carvalho et al., 2005). Ten to twelve groups of 20 flies were
collected, washed once with 0.1% BSA, and assayed for label retention on
a scintillation counter. Fatty acid uptake was determined in a similar manner,
using 3H-oleic acid (Moravek Biochemicals) at a final concentration of 3 mC/ml.
Treatment with Orlistat was conducted by growing flies on a high-nutrient
molasses medium (Bloomington cornmeal, yeast, and molasses media) with
or without 2 mMOrlistat for 5–7 days. TAG levels were then assayed as above.
All data shown are from two parallel data sets of six samples/stock/condition
compiled together and repeated at least three times. Dietary lipid supplemen-
tation was performed by transferring mature adult males to lipid-depleted
1.0 SY for 5–7 days. This mediumwas prepared by extracting the yeast extract
and agar components of the SY medium overnight with chloroform, followed
by a second 4 hr chloroform extraction. Both components were then allowed
to dry for 2–3 days in a fume hood. The lipid-depleted medium was supple-
mented with either free fatty acids (5 mg/ml stearic acid and 5 mg/ml oleic
acid, ChemService) or TAG (5 mg/ml glycerol tristearate and 5 mg/ml glycerol
trioleate, ChemService). All data shown are from two collections of six samples
collected from each genotype under each condition. Each experiment was
repeated at least three times.
Microarrays
Adult male CanS and DHR961 flies were collected 1–2 days after eclosion and
allowed to age for 7 days on normal medium. RNA was extracted from these
animals using Trizol (GIBCO) and purified on RNAeasy columns (QIAGEN).
All samples were prepared in triplicate to facilitate subsequent statistical anal-
ysis. Probe labeling, hybridization to Affymetrix GeneChipDrosophilaGenome
2.0 Arrays, and scanning were performed by the University of Maryland Micro-
array Core Facility. Raw data were subjected to quantile normalization using
R statistical analysis software, and gene expression changes were determined
using SAM 2.0, with a <5%estimated false positive rate and a 1.5-fold cutoff in
expression level (Tusher et al., 2001). Comparison between microarray data
sets was performed using Microsoft Access.
Statistical Analyses
Statistical significance was calculated using an unpaired two-tailed Student’s
t test with unequal variance. All quantitative data are reported as the mean ±
SEM.
ACCESSION NUMBERS
Microarray data from this study can be accessed at the National Center for
Biotechnology Information Gene Expression Omnibus (NCBI GEO) under
accession number GSE18576.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, one table, and nine figures and can be found with this
article online at http://www.cell.com/cell-metabolism/supplemental/S1550-
4131(09)00336-2.
ACKNOWLEDGMENTS
We thank M. Horner for providing the DHR962X stock, B. Milash for advice on
microarray analysis;M. VanGilst for suggesting the use of Orlistat and for tech-
nical advice with these experiments; J. Tennessen, A.-F. Ruaud, L. Palanker,
M. Horner, and M. Metzstein for helpful discussions; and M. Horner,
A.-F. Ruaud, and J. Tennessen for comments on the manuscript. M.H.S.
was supported by a National Institutes of Health (NIH) Developmental Biology
Predoctoral Training Grant (5T32 HD07491). This research was supported by
NIH grant 1R01DK075607.
Received: May 19, 2009
Revised: October 3, 2009
Accepted: October 27, 2009
Published: December 1, 2009
REFERENCES
Burmester, T., Antoniewski, C., and Lepesant, J.A. (1999). Ecdysone-regula-
tion of synthesis and processing of fat body protein 1, the larval serum protein
receptor of Drosophila melanogaster. Eur. J. Biochem. 262, 49–55.
Carvalho, G.B., Kapahi, P., and Benzer, S. (2005). Compensatory ingestion
upon dietary restriction in Drosophila melanogaster. Nat. Methods 2, 813–815.
Chawla, A., Repa, J.J., Evans, R.M., and Mangelsdorf, D.J. (2001). Nuclear
receptors and lipid physiology: opening the X-files. Science 294, 1866–1870.
Chintapalli, V.R., Wang, J., and Dow, J.A. (2007). Using FlyAtlas to identify
better Drosophila melanogaster models of human disease. Nat. Genet. 39,
715–720.
Cell Metabolism
Drosophila DHR96 Functions in Lipid Metabolism
Cell Metabolism 10, 481–490, December 2, 2009 ª2009 Elsevier Inc. 489
	  	  
36	  
Chung, H., Sztal, T., Pasricha, S., Sridhar, M., Batterham, P., and Daborn, P.J.
(2009). Characterization of Drosophila melanogaster cytochrome P450 genes.
Proc. Natl. Acad. Sci. USA 106, 5731–5736.
Farber, S.A., Pack, M., Ho, S.Y., Johnson, I.D., Wagner, D.S., Dosch, R., Mul-
lins, M.C., Hendrickson, H.S., Hendrickson, E.K., and Halpern, M.E. (2001).
Genetic analysis of digestive physiology using fluorescent phospholipid
reporters. Science 292, 1385–1388.
Fisk, G.J., and Thummel, C.S. (1995). Isolation, regulation, and DNA-binding
properties of three Drosophila nuclear hormone receptor superfamily
members. Proc. Natl. Acad. Sci. USA 92, 10604–10608.
Gerisch, B., Weitzel, C., Kober-Eisermann, C., Rottiers, V., and Antebi, A.
(2001). A hormonal signaling pathway influencing C. elegans metabolism,
reproductive development, and life span. Dev. Cell 1, 841–851.
Gershman, B., Puig, O., Hang, L., Peitzsh, R.M., Tatar, M., and Garofalo, R.S.
(2006). High resolution dynamics of the transcriptional response to nutrition in
Drosophila: a key role for dFOXO. Physiol. Genomics 29, 24–34.
Gro¨nke, S., Beller, M., Fellert, S., Ramakrishnan, H., Jackle, H., and Kuhnlein,
R.P. (2003). Control of fat storage by a Drosophila PAT domain protein. Curr.
Biol. 13, 603–606.
Gro¨nke, S., Mildner, A., Fellert, S., Tennagels, N., Petry, S., Muller, G., Jackle,
H., and Kuhnlein, R.P. (2005). Brummer lipase is an evolutionary conserved fat
storage regulator in Drosophila. Cell Metab. 1, 323–330.
Gro¨nke, S., Muller, G., Hirsch, J., Fellert, S., Andreou, A., Haase, T., Jackle, H.,
and Kuhnlein, R.P. (2007). Dual lipolytic control of body fat storage and mobi-
lization in Drosophila. PLoS Biol. 5, e137. 10.1371/journal.pbio.0050137.
Heck, A.M., Yanovski, J.A., and Calis, K.A. (2000). Orlistat, a new lipase inhib-
itor for the management of obesity. Pharmacotherapy 20, 270–279.
Hegedus, D., Erlandson, M., Gillott, C., and Toprak, U. (2009). New insights
into peritrophic matrix synthesis, architecture, and function. Annu. Rev. Ento-
mol. 54, 285–302.
Hennig, K.M., Colombani, J., and Neufeld, T.P. (2006). TOR coordinates bulk
and targeted endocytosis in the Drosophila melanogaster fat body to regulate
cell growth. J. Cell Biol. 173, 963–974.
Hoekstra, M., Lammers, B., Out, R., Li, Z., Van Eck, M., and Van Berkel, T.J.
(2009). Activation of the nuclear receptor PXR decreases plasma LDL-choles-
terol levels and induces hepatic steatosis in LDL receptor knockout mice. Mol.
Pharm. 6, 182–189.
Horner, M., Pardee, K., Liu, S., King-Jones, K., Lajoie, G., Edwards, A., Krause,
H.M., and Thummel, C.S. (2009). The Drosophila DHR96 nuclear receptor
binds cholesterol and regulates cholesterol homeostasis. Genes Dev., in
press.
Huang, X., Warren, J.T., Buchanan, J., Gilbert, L.I., and Scott, M.P. (2007).
Drosophila Niemann-Pick type C-2 genes control sterol homeostasis and
steroid biosynthesis: a model of human neurodegenerative disease. Develop-
ment 134, 3733–3742.
King-Jones, K., Horner, M.A., Lam, G., and Thummel, C.S. (2006). The DHR96
nuclear receptor regulates xenobiotic responses in Drosophila. Cell Metab. 4,
37–48.
Li, H.M., Buczkowski, G., Mittapalli, O., Xie, J., Wu, J., Westerman, R., Sche-
merhorn, B.J., Murdock, L.L., and Pittendrigh, B.R. (2008). Transcriptomic
profiles of Drosophila melanogaster third instar larval midgut and responses
to oxidative stress. Insect Mol. Biol. 17, 325–339.
Ligumsky, M., Granot, E., Branski, D., Stankiewicz, H., and Goldstein, R.
(1990). Isolated lipase and colipase deficiency in two brothers. Gut 31,
1416–1418.
Maglich, J.M., Stoltz, C.M., Goodwin, B., Hawkins-Brown, D., Moore, J.T., and
Kliewer, S.A. (2002). Nuclear pregnane x receptor and constitutive androstane
receptor regulate overlapping but distinct sets of genes involved in xenobiotic
detoxification. Mol. Pharmacol. 62, 638–646.
Maglich, J.M., Watson, J., McMillen, P.J., Goodwin, B., Willson, T.M., and
Moore, J.T. (2004). The nuclear receptor CAR is a regulator of thyroid hormone
metabolism during caloric restriction. J. Biol. Chem. 279, 19832–19838.
Maglich, J.M., Lobe, D.C., and Moore, J.T. (2009). The nuclear receptor CAR
(NR1I3) regulates serum triglyceride levels under conditions of metabolic
stress. J. Lipid Res. 50, 439–445.
Mair, W., Piper, M.D., and Partridge, L. (2005). Calories do not explain exten-
sion of life span by dietary restriction in Drosophila. PLoS Biol. 3, e223.
10.1371/journal.pbio.0030223.
Moreau, A., Vilarem, M.J., Maurel, P., and Pascussi, J.M. (2008). Xenorecep-
tors CAR and PXR activation and consequences on lipid metabolism, glucose
homeostasis, and inflammatory response. Mol. Pharm. 5, 35–41.
Nakamura, K., Moore, R., Negishi, M., and Sueyoshi, T. (2007). Nuclear preg-
nane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of
lipid metabolism in fasting mouse liver. J. Biol. Chem. 282, 9768–9776.
Palanker, L., Necakov, A.S., Sampson, H.M., Ni, R., Hu, C., Thummel, C.S.,
and Krause, H.M. (2006). Dynamic regulation of Drosophila nuclear receptor
activity in vivo. Development 133, 3549–3562.
Palanker, L., Tennessen, J.M., Lam, G., and Thummel, C.S. (2009). Drosophila
HNF4 regulates lipid mobilization and beta-oxidation. Cell Metab. 9, 228–239.
Phillips, M.D., and Thomas, G.H. (2006). Brush border spectrin is required for
early endosome recycling in Drosophila. J. Cell Sci. 119, 1361–1370.
Shostak, Y., Van Gilst, M.R., Antebi, A., and Yamamoto, K.R. (2004). Identifi-
cation of C. elegans DAF-12-binding sites, response elements, and target
genes. Genes Dev. 18, 2529–2544.
Sonoda, J., Pei, L., and Evans, R.M. (2008). Nuclear receptors: decoding
metabolic disease. FEBS Lett. 582, 2–9.
Telfer, W.H., and Kunkel, J.G. (1991). The function and evolution of insect
storage hexamers. Annu. Rev. Entomol. 36, 205–228.
Timsit, Y.E., and Negishi, M. (2007). CAR and PXR: the xenobiotic-sensing
receptors. Steroids 72, 231–246.
Tusher, V.G., Tibshirani, R., and Chu, G. (2001). Significance analysis of micro-
arrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA
98, 5116–5121.
Ueda, A., Hamadeh, H.K., Webb, H.K., Yamamoto, Y., Sueyoshi, T., Afshari,
C.A., Lehmann, J.M., and Negishi, M. (2002). Diverse roles of the nuclear
orphan receptor CAR in regulating hepatic genes in response to phenobarbital.
Mol. Pharmacol. 61, 1–6.
Voght, S.P., Fluegel, M.L., Andrews, L.A., and Pallanck, L.J. (2007). Drosophila
NPC1b promotes an early step in sterol absorption from themidgut epithelium.
Cell Metab. 5, 195–205.
Willson, T.M., and Kliewer, S.A. (2002). PXR, CAR and drug metabolism. Nat.
Rev. Drug Discov. 1, 259–266.
Zhou, J., Zhai, Y., Mu, Y., Gong, H., Uppal, H., Toma, D., Ren, S., Evans, R.M.,
and Xie, W. (2006). A novel pregnane X receptor-mediated and sterol regula-
tory element-binding protein-independent lipogenic pathway. J. Biol. Chem.
281, 15013–15020.
Cell Metabolism
Drosophila DHR96 Functions in Lipid Metabolism
490 Cell Metabolism 10, 481–490, December 2, 2009 ª2009 Elsevier Inc.
	  







COORDINATION OF TRIGLYCERIDE AND CHOLESTEROL HOMEOSTASIS  
BY DHR96 AND THE DROSOPHILA  






















Coordinate regulation of lipid metabolism is central to human health, with 
disruption of this process leading to a range of metabolic disorders, including obesity and 
cardiovascular disease. Normal lipid homeostasis is maintained by balancing dietary lipid 
uptake and synthesis with lipid catabolism and excretion. Under normal feeding 
conditions, dietary lipids such as triacylglycerol (TAG) and cholesterol esters are broken 
down into free fatty acids, monoacylglycerols, and free sterols in the lumen of the 
intestine. These digested lipids can then be absorbed by the intestinal cells, where TAG is 
resynthesized and packaged together with cholesterol, cholesterol esters, and carrier 
proteins to form lipoprotein particles that are released into the circulatory system to be 
trafficked throughout the body. These trafficked lipids can be either utilized by cells or 
deposited in storage tissues such as the adipose and liver. Under conditions of excess 
lipids, stored TAG and cholesterol esters are broken down and free fatty acids can be 
utilized for energy, while excess cholesterol is modified into polar sterols in the liver and 
excreted from the intestine (Ikonen, 2008; Lusis and Pajukanta, 2008).  
Nuclear receptors (NRs) are ligand-regulated transcription factors that play 
essential roles in multiple aspects of lipid homeostasis. Many NRs bind small lipophilic 
compounds such as fatty acids, sterols, and other metabolic intermediates, and coordinate 
multiple aspects of metabolism by directing specific changes in gene expression. One 
example of this is the LXR/FXR subclass of NRs that play central roles in TAG 
metabolism and cholesterol homeostasis. Previous studies of LXRa (NR1H3) in mice 
have shown this receptor binds oxysterols and promotes the modification and clearance 
of excess sterols by cholesterol efflux and reverse cholesterol transport (Kalaany and 
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Mangelsdorf, 2006). In addition, LXRa is required to maintain proper TAG levels, at 
least in part through the regulation of SREBP-mediated fat synthesis (Schultz et al., 
2000). LXRa activity is thus central to both TAG and cholesterol homeostasis, although 
much remains to be learned about the roles of specific LXR target genes in mediating 
these key metabolic functions. 
We have been studying a Drosophila homolog of LXRa, DHR96, as a simple 
system to understand the physiological and molecular roles for this family of NRs and 
their target genes. Biochemical and genetic studies of DHR96 have shown that it shares 
the central metabolic functions of its mammalian counterpart. DHR96 binds cholesterol 
and is required for normal cholesterol homeostasis, with DHR96 null mutants exhibiting a 
20-30% increase in whole animal cholesterol levels due, at least in part, to increased 
npc1b expression (Horner et al., 2009; Bujold et al., 2010). In addition, DHR96 mutants 
display an approximate 50% decrease in whole animal TAG levels. This decrease in TAG 
arises, in part, from an inability of the DHR96 mutant to break down dietary TAG due to 
a major decrease in the expression of the intestinal lipase Magro (CG5932) (Sieber and 
Thummel, 2009). Interestingly, magro transcription is responsive to dietary cholesterol 
levels and this regulation is dependent on DHR96 function, providing a potential link 
between cholesterol levels, DHR96, and TAG homeostasis (Horner et al., 2009; Bujold et 
al., 2010). Moreover, while Magro protein is most similar to mammalian gastric lipase 
(38% identity, 56% similarity), the second most homologous mammalian protein is LipA 
(32% identity 50% similarity), which has both TAG lipase and cholesterol esterase 
activities (Ameis et al., 1994). Consistent with these enzymatic functions, mutations in 
LipA lead to a major decrease in white adipose tissue along with elevated levels of stored 
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and circulating cholesterol in mice (Du et al., 1998; Du et al., 2001). LipA mutants also 
display excess cholesterol esters and TAG in the intestine and liver – hallmarks of 
Wolman’s disease and Cholesterol Ester Storage Disease (CESD), which are caused by 
mutations in human LipA (Crocker et al., 1965; Kyriakides et al., 1970; Burke and 
Schubert, 1972). Taken together, these observations raise the possibility that, in addition 
to maintaining TAG homeostasis, magro may have a critical role in regulating cholesterol 
homeostasis, and that DHR96 may function through magro to help coordinate TAG and 
cholesterol metabolism.  
In this study we show that loss of magro function leads to a ~20-25% increase in 
whole animal cholesterol levels, similar to that seen in the DHR96 mutant. Biochemical 
and genetic studies reveal that, like LipA, Magro has cholesterol esterase activity, and 
this enzyme is required in intestinal cells to clear excess cholesterol. In contrast, the TAG 
lipase activity of Magro arises from the anterior end of the gut and acts in the intestinal 
lumen to facilitate dietary fat uptake. Restoring magro expression in the intestine of the 
DHR96 mutant is sufficient to fully rescue the lean phenotype and partially rescue the 
cholesterol accumulation defect seen in DHR96 mutants. Our data support the model that 
DHR96 functions through magro in the intestine to coordinate both dietary TAG 
breakdown and the clearance of excess sterols. These studies provide new insights into 
the mechanisms by which nuclear receptors can promote the clearance of excess sterols 






Materials and methods 
Fly stocks 
The following stocks were used in this study: Canton S, DHR961 (King-Jones et 
al., 2006), Mex-Gal4 (Phillips and Thomas, 2006), Act-Gal4/CyO (Bloomington # 25374), 
UAS-magro (Sieber and Thummel, 2009), UAS-DHR96 (Horner et al., 2009), UAS-
MAGRO-RNAi (NIG Fly),  bab1-GAL4/TM3 (Cabrera et al., 2002). Flies were maintained 
on Standard Bloomington Stock Center medium with malt at 25°C.  
 
magro-EGFP genomic transgenic line 
The genomic magro-EGFP transgenic stock was made using oligonucleotide 
primers 5’- GAATTCGGCGCGCCCCACTAAACCACGCCGCTGTTG -3’ and 5’- 
GAATTCCCGCGGTAAGCGACCTTCGTAGGAGT-3’ to amplify a 6.32 kb genomic 
fragment spanning the magro locus, containing 5 kb of promoter sequence and the entire 
1.3 kb protein coding region. The 3’ end of this fragment contains a mutation that 
converts the TAG stop codon into a TTA codon to allow translational read though into 
EGFP. This fragment was digested with Asc1 and SacII and the resulting fragment was 
ligated into the corresponding sites of the pStinger P-element vector (Barolo et al., 2004). 
Oligonucleotide primers, 5’-GAATTCCCGCGGAAATCGGCCAATAAAAGAATCCG-
3’ and 5’- GAATTCACTAGTAGCCTTACGATATCTAATCGACTAAAG-3’, were 
then used to amplify a 302 bp fragment that spans the endogenous 3’-UTR of magro. 
This fragment was digested with SpeI and SacII and cloned into the corresponding sites 
in the pStinger-magro vector. The EGFP coding sequence was then amplified from 




GAATTCCCGCGGCTACAGCTCGTCCATGCCGAGAG-3’. The resulting fragment 
was digested and ligated into the SacII site in the vector between the magro coding 
sequence and the 3’ UTR, resulting in the genomic magro-EGFP translational fusion 
construct. This vector was integrated into the w1118 genome following standard methods.  
 
Metabolite assays 
Newly eclosed adult male flies were aged 5-7 days prior to use for all experiments. 
Pancreatin dietary supplementation was conducted by raising flies for their entire life 
cycle in the presence of 5 mg/ml pancreatin (Sigma), after which 7-day-old adult male 
flies were collected and assayed for TAG and cholesterol. TAG and cholesterol assays 
were conducted as described (Horner et al., 2009; Sieber and Thummel, 2009). All results 
shown are compiled from two parallel data sets from six samples collected from each 
genotype under each condition, and repeated at least three times. To measure cholesterol 
ester levels, 30 adult male flies were collected, washed twice with 1X PBS, and 
homogenized in 250 µl of 1X PBST. The total volume was brought to 1.0 ml with 1X 
PBST and the samples were divided into two 500 µl aliquots. Both aliquots were 
sonicated three times for 30 seconds, after which 10 µl of cholesterol esterase (Sigma) 
was added to one aliquot while the other aliquot served as an undigested control. Samples 
were incubated overnight at 37°C with periodic vortexing. Lipids were extracted using a 
2:1 chloroform-methanol mixture and dried by vacuum centrifugation. Lipids were 
solubilized using 500 µl 1X PBST by vortexing, followed by sonication (6x30 seconds). 
A 25 µl lipid sample was added to 25 µl of Amplex reaction buffer in each well of a 
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black 96 well plate, followed by 90 µl of Amplex reagent (Amplex Red Cholesterol 
Assay Kit, Invitrogen). The plates were mixed and incubated at 37°C for 30 minutes. 
Samples were then assayed according to the kit instructions and measured in a Molecular 
Devices SpectraMax M2 fluorometer. The readings from undigested samples were 
subtracted from those of the digested samples to determine the relative levels of 
cholesterol esters. The data presented were compiled from three replicate samples per 
genotype and were repeated at least three times.  
 
In vivo cholesterol esterase activity assay 
Cholesterol ester substrate for the assay was made by adding 40 mg cholesterol 
acetate (Sigma) to 4 mls of Amplex reaction buffer (Invitrogen). The mixture was 
sonicated (6x30 seconds) to make a lipid suspension, incubated for 15 minutes at 500C, 
and centrifuged at 12,000 x G for 3 minutes to clear the suspension of insoluble 
cholesterol acetate. Intestines from 30 adult male flies were dissected and homogenized 
in 100 µl Amplex reaction buffer (Invitrogen) and centrifuged at 12,000 x G for 2 
minutes to clear the lysate. Forty microliters of reaction buffer and 10 µl of cholesterol 
ester solution were added to each well in a black 96 well plate. Cleared lysate was then 
added to each well, except for the nondigested controls, and mixed by pipetting. Ninety 
microliters  of Amplex reagent (Amplex Red Cholesterol Assay Kit, Invitrogen) was 
added to each well followed by a 30-minute incubation at 370C. Fluorescence for each 
well was then measured according to the kit instructions. The readings from undigested 
samples were subtracted from those of the digested samples to determine the amount of 
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free cholesterol released. These data presented were compiled from three replicate 
samples per genotype and were repeated at least three times.  
 
Statistical analyses 
Statistical analysis was done using an unpaired two-tailed Student’s t-test with 
equal variance. All quantitative data are reported as the mean ± SEM.  
 
Results 
magro is required for normal cholesterol homeostasis 
The regulation of magro transcription by dietary cholesterol combined with its 
significant homology to LipA prompted us to test if magro function is required for 
cholesterol homeostasis. DHR961 null mutants grown on a normal diet display ~20-30% 
elevated levels of whole animal cholesterol compared to genetically matched wild-type 
controls (Figure 3.1A), similar to the results seen when DHR96 mutant larvae are 
subjected to a high cholesterol diet (Horner et al., 2009). Interestingly, RNAi-mediated 
silencing of magro expression, as done previously (Sieber and Thummel, 2009), leads to 
a similar phenotype relative to the Act-GAL4/+ and UAS-magro RNAi/+ controls (Figure 
3.1A). Taken together with our earlier work, which showed that both DHR96 mutants and 
magro RNAi animals have significantly lower levels of TAG, these data suggest that 
DHR96 functions through transcriptional regulation of magro to coordinate TAG and 




Figure 3.1 magro maintains proper cholesterol levels and has cholesterol esterase 
activity. 
(A) RNAi for magro results in elevated cholesterol levels similar to those seen in DHR96 
mutants. Wild-type (WT), Act-GAL4/+, and UAS-magro-RNAi/+ control flies, along with 
DHR961 mutants and Act-GAL4/UAS-magro-RNAi animals (Act>RNAi) were assayed for 
total cholesterol levels. These data were normalized to protein levels and are presented 
relative to a wild-type level of 100%. (B) RNAi for magro results in reduced intestinal 
cholesterol esterase activity. Intestines dissected from both Act-Gal4/+ control and Act-
GAL4/UAS-magro-RNAi (magro RNAi) animals were homogenized and increasing 
amounts of lysate were tested for cholesterol esterase (CE) activity by assaying for the 
release of free cholesterol from a cholesterol acetate substrate. (C) Purified Magro-GST 
protein has cholesterol esterase activity. Recombinant GST and Magro-GST were 
purified as described (Sieber and Thummel, 2009) and increasing amounts of protein 
were assayed for cholesterol esterase (CE) activity. (D) RNAi for magro results in 
elevated levels of esterified cholesterol. Free, esterified, and total cholesterol levels were 
measured from Mex-GAL4/+ control and Mex-GAL4/UAS-magro-RNAi (magro RNAi) 


















































































































magro regulates cholesterol homeostasis by breaking down stored  
cholesterol esters 
Because mammalian LipA is known to cleave cholesterol esters in addition to its 
TAG lipase activity, we tested if Magro shares these dual enzymatic functions (Ameis et 
al., 1994). The expression of magro was effectively silenced by RNAi and extracts from 
dissected intestines were tested for cholesterol esterase activity. While control intestinal 
lysates exhibit a high level of cholesterol esterase activity in a dose-dependent manner, 
the lysates from magro RNAi animals display a significant ~50% decrease in enzymatic 
function (Figure 3.1B). Moreover, purified recombinant Magro-GST efficiently cleaves a 
cholesterol ester substrate in vitro, demonstrating that these effects are a direct result of 
Magro enzymatic activity (Figure 3.1C). Thus, taken together with our earlier 
biochemical studies, this result shows that Magro is a bifunctional enzyme that can act as 
both a TAG lipase and cholesterol esterase (Sieber and Thummel, 2009). 
 If decreased cholesterol esterase activity in the intestine is the cause of the 
elevated cholesterol levels seen in the magro RNAi animals then we should see a specific 
increase in stored cholesterol esters in these animals. To test this possibility, we used the 
Mex-GAL4 driver to specifically silence magro expression in the intestine and then 
measured free cholesterol, total cholesterol, and cholesterol esters (Figure 3.1D). Free 
cholesterol levels are the same in control and Mex>magro RNAi animals, and total 
cholesterol levels were elevated upon magro RNAi, similar to the result seen when the 
ubiquitous Act–GAL4 driver is used to direct magro RNAi (Figure 3.1A). Importantly, 
cholesterol ester levels are also significantly higher in Mex>magro RNAi animals relative 
to the Mex-GAL4/+ controls (Figure 3.1D). Taken together, these data support the model 
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that Magro maintains cholesterol homeostasis through its ability to directly break down 
stored cholesterol esters in the intestine.  
 
magro is expressed throughout the digestive tract 
Although microarray studies have demonstrated that magro is expressed 
specifically in the midgut, its expression within this tissue remains undefined (Drysdale, 
2008). We therefore examined Magro expression in the digestive tract using a magro-
EGFP transgenic line. This construct contains ~7 kb of genomic DNA spanning the 
magro locus with 5 kb of upstream promoter sequences and the EGFP gene fused in-
frame to the 3’-end of the magro protein coding region. EGFP expression in these 
animals revealed that Magro is present throughout the intestine with the highest levels of 
protein accumulation in the anterior region of the proventriculus of the digestive tract 
(also called the cardia) (Figure 3.2A). The proventriculus is a bulb shaped structure that 
consists of three distinct cell layers (Figure 3.3). The esophagus, which enters from the 
anterior end and runs to the base of the proventriculus, folds back on itself to form a 
second, internal cell layer that runs back to the anterior end of the structure and again 
folds back on itself to form the outermost cell layer, which is continuous with the body of 
the intestine. Magro-EGFP is expressed in the anterior half of the outermost layer of cells 
in the proventriculus (Figure 3.2C, arrow). In addition, protein is clearly visible in large 
vesicles that lie posterior to this region of expression (Figure 3.2C-E, yellow boxes). 
These are acidic vesicles that stain positive for Lysotracker Red (Figure 3.2F-H) 
consistent with the acid lipase activity of Magro and LipA. Interestingly, visualization of 




Figure 3.2 Magro is expressed in the proventriculus and midgut 
A genomic magro-EGFP fusion construct was used to visualize the distribution of Magro 
expression in mid-third instar larvae. Magro-EGFP (green) expression is restricted to the 
intestine and accumulates to high levels in the anterior region of the proventriculus (A, 
arrow in C). Antibody staining for EGFP also revealed lower levels of punctate 
expression in the cytoplasm of enterocytes (B). Higher resolution images of the 
proventriculus revealed Magro-EGFP in large vesicles that extend from the abundant 
expression at the anterior end of the proventriculus toward the junction with the midgut 
lumen (yellow boxes in C,D,E, shown in panels F,G,H). Lysotracker Red stains the large 

















Figure 3.3 Schematic representation of the Drosophila proventriculus. 
The proventriculus is a bulb shaped structure that consists of three distinct cell layers. 
The esophagus, which enters from the anterior end (top of figure) and runs to the base of 
the proventriculus, folds back on itself to form a second, internal cell layer that runs back 
to the anterior end of the proventriculus and again folds back on itself to form the 
outermost cell layer, which is continuous with the body of the intestine (King, 1988). 
magro-EGFP protein (green) is abundantly expressed in the anterior outermost cell layer, 
and released as vesicles that appear to be localized to the intercellular space where the 










Figure 3.5. Schematic representation of the Drosophila proventriculus.  
The proventriculus is a bulb shaped structure that consists of three distinct cell layers. The 
esophagus, which enters from the anterior end (top of figure) and runs to the base of the 
proventriculus, folds ack on itself to fo m a second, internal cell layer at runs back to the 
anterior end of the proventriculus and again folds back on itself to form the outermost cell 
layer, which is continuous with the body of the intestine (King, 1988). magro-EGFP protein 
(green) is abundantly expressed in the anterior outermost cell layer, and released as vesicles 




Figure 3.4 CD8-GFP positive vesicles move within the proventriculus Tub-GAL4 was 
used to drive expression of the UAS-CD8-GFP membrane marker to visualize 
membrane-bound vesicles in the posterior region of the proventriculus (red box in 
diagram at bottom). Images were captured at 10 second intervals for 80 seconds, 
revealing rapid vesicle movement toward the base of the proventriculus. Two vesicles are 
marked with white and yellow asterisks. 
 
  
intestine, providing a potential mechanism to deliver digestive enzymes, such as Magro, 
into the intestinal lumen (Figure 3.4). Lower levels of Magro-EGFP protein can also be 
seen in the major cell type of the intestine, the enterocytes, in a punctate cytoplasmic 
pattern (Figure 3.2B). Interestingly, we do not observe Magro-EGFP in large acidic 
Lysotracker-positive vesicles in these cells. Taken together, these observations suggest 
that Magro is trafficked differently in different cell types of the digestive tract and raise 
the possibility that that the cholesterol esterase and TAG lipase activities of this enzyme 
are spatially seperated. 
10 sec 20 sec 30 sec 40 sec
50 sec 60 sec 70 sec 80 sec







Figure 3.6. CD8-GFP positive vesicles move within the proventriculus  
Tub-GAL4 was used to drive expression of the UAS-CD8-GFP membrane marker to visualize 
membran -bound vesicles in t  posterior region of the provent iculus (red box in diagram at 
bottom). Images were captured at 10 second intervals for 80 seconds, revealing rapid vesicle 





magro acts within the intestinal lumen to maintain  
TAG homeostasis 
As a first step toward determining if the enzymatic activities of Magro are 
regionally localized within the intestine, we examined if restoring Magro enzymatic 
functions in the lumen of the gut could rescue the lipid metabolic defects seen in the 
DHR96 mutant and magro RNAi animals. Both stocks were grown on a diet 
supplemented with pancreatin, which is a mixture of pancreatic enzymes that includes 
TAG lipase and cholesterol esterase activities, after which whole animal TAG and 
cholesterol levels were determined. While pancreatin supplementation had no effect on 
TAG levels in either Canton S or Act-GAL4/+ control animals, this diet restored wild-
type levels of TAG in both DHR96 and magro RNAi animals (Figure 3.5 A,B). 
Conversely, pancreatin supplementation had no impact on the elevated cholesterol levels 
seen in the DHR96 or magro RNAi animals (Figure 3.5 C,D). These results are consistent 
with those seen when wild-type flies are treated with Orlistat (tetrahydrolipstatin), which 
acts as a competitive inhibitor of secreted lipases and cholesterol esterases inside the 
lumen of the intestine (Borgstrom, 1988). Although Orlistat treatment is sufficient to 
decrease whole animal TAG levels, as seen previously (Sieber and Thummel, 2009), no 
significant effect is seen on the levels of total cholesterol (Figure 3.6). These data confirm 
our earlier studies indicating that Magro functions in the intestinal lumen to maintain 
appropriate levels of TAG, and demonstrate that its effects on cholesterol homeostasis are 







Figure 3.5 Magro enzymatic activity is not required in the intestinal lumen to 
maintain cholesterol homeostasis  
Wild-type (WT) and Act-GAL4/+ controls, along with DHR961 mutants and Act-
GAL4/UAS-magro-RNAi (mag RNAi) animals, were raised on medium supplemented 
with 2 mg/mls pancreatin. Mature adults were collected and assayed for TAG (A,B) and 
cholesterol (C,D) levels. The data were normalized to protein levels and are presented 
relative to a wild-type level of 100%. Pancreatin supplementation is sufficient rescue the 
reduced TAG levels in both DHR96 mutants and magro RNAi animals (A, B), but has no 
significant effect on their increased cholesterol levels (C,D). Error bars represent ±SEM. 






























































































Figure 3.6 Orlistat treatment decreases TAG levels, but has no effect on cholesterol 
levels in wild-type flies  
 
Mature adult male Canton S flies were transferred to a diet supplemented with 2.0 µM 
Orlistat for seven days, after which TAG and cholesterol levels were determined. The 
data was normalized to protein levels and are presented relative to a level of 100% for 
treatment with vehicle alone. These results were compiled from six replicate samples and 











































Figure 3.7. Orlistat tr atment decreas s TAG levels, but has no effect on 
cholesterol level  in wild-type flies  
Mature adult male Canton S flies were transferred to a diet supplemented with 2.0 µM 
Orlistat for seven days, after which TAG and cholesterol levels ere determined. The 
data was ormalized to protein levels and are pres nted r lative to a l vel of 100% for 
treatment with vehicle alon . These results were compiled from six replicate samples 






Figure 3.7 bab1-GAL4 drives expression in the proventriculus region of the intestine  
 
The bab1-GAL4 transgene was used to drive the expression of UAS-NLS-DsRed, 
confirming that bab1- GAL4 is highly expressed in the proventriculus region of the 





magro functions in the proventriculus to promote the breakdown of 
dietary TAG 
The apparent vesicular trafficking of Magro protein from the proventriculus 
toward the body of the midgut provides a mechanism to explain its delivery into the 
lumen of the intestine. If this model is correct, then disrupting magro function 
specifically in the proventriculus should have an effect on TAG levels, but little or no 
effect on cholesterol homeostasis. To test this hypothesis, we used the bab1-GAL4 driver, 
which is expressed highly in the proventriculus, with lower levels near the midgut-
hindgut junction (Figure 3.7)(Cabrera et al., 2002). Using this construct to direct magro 
RNAi resulted in a significant decrease in whole animal TAG levels relative to the bab1-
GAL4/+ and UAS-magro RNAi/+ controls (Figure 3.8A). This level of reduction is  
bab1>NLS-DsRed DIC Overlay
Figure 3.8. bab1-GAL4 drives expression in the proventriculus region of the intestine 
The bab1-GAL4 transgene was used to drive the expression of UAS-NLS-DsRed, confirming that bab1-
GAL4 is highly expressed in the proventriculus region of the intestine (arrow), with low level expression 





Figure 3.8 DHR96 regulation of magro in distinct regions of the intestine 
coordinates TAG and cholesterol homeostasis  
 
 
(A,B) Proventriculus-specific RNAi for magro results in reduced levels of TAG, but has 
no effect on cholesterol. bab1-GAL4/+ and UAS-magro-RNAi/+ control flies, along with 
bab1-GAL4/UAS-magro-RNAi (bab1>mag-RNAi) animals were assayed for (A) total 
TAG and (B) cholesterol levels. The data were normalized to protein levels and are 
presented relative to a wild-type level of 100%. (C) Midgut-specific expression of magro 
is sufficient to partially rescue the elevated cholesterol levels in DHR96 mutants. Wild-
type (WT) and DHR96 mutants, carrying either the Mex-GAL4 driver alone, UAS-magro 
transgene alone, or both Mex-GAL4 and UAS-magro (Mex>mag) to express magro in the 
midgut, were assayed for total cholesterol levels. The data were normalized to protein 
levels and are presented relative to a wild-type level of 100%. (D,E) Proventriculus-
specific expression of magro is sufficient to rescue the lean phenotype of DHR96 mutants, 
but has no effect on its elevated cholesterol levels. Wild-type (WT) and DHR96 mutants, 
carrying either the bab1-GAL4 driver alone, UAS-magro transgene alone, or both bab1-
GAL4 and UAS-magro (bab1>mag) to express magro in the proventriculus, were assayed 
for (D) TAG and (E) cholesterol levels. The data were normalized to protein levels and 
are presented relative to a wild-type level of 100%. Results are compiled from six 




















































































































































































































similar to that seen when magro function is disrupted using the pan-intestinal Mex-GAL4 
driver (Sieber and Thummel, 2009), suggesting that the TAG metabolic functions of this 
enzyme are restricted to the proventriculus. In contrast, proventriculus-specific magro 
RNAi has no effect on total cholesterol levels in these animals, indicating that the  
 
 
DHR96 regulates major aspects of lipid metabolism through its 
 
target gene magro 
If decreased magro expression is physiologically relevant to the cholesterol 
accumulation phenotype seen in DHR96 mutants, then restoring magro function in these 
animals should rescue their defect in cholesterol homeostasis. To test this hypothesis, we 
expressed wild-type magro in the intestine of the DHR96 mutant using Mex-GAL4 and 
measured whole animal cholesterol levels. Relative to the UAS-magro/+ and Mex-
GAL4/+ controls, we found that magro expression in the intestine of the DHR96 mutant 
is sufficient to partially rescue the cholesterol accumulation phenotype seen in these 
animals (Figure 3.8C). The fact that this rescue is not complete is consistent with the 
multiple levels of cholesterol metabolism that are regulated by DHR96 (Horner et al., 
2009; Bujold et al., 2010). Moreover, specific expression of magro in the proventriculus 
of DHR96 mutants effectively rescues their lean phenotype (Figure 3.8D), but has no 
significant effect on the elevated levels of cholesterol in these animals (Figure 3.8E). 
Taken together with our other data, these results indicate that the region-specific 
enzymatic activities of Magro correspond to the lipid metabolic functions of DHR96. 
DHR96 regulation of magro expression in the proventriculus maintains an appropriate 
level of TAG lipase activity in the intestinal lumen to facilitate dietary lipid break down, 
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In addition to its essential role in nutrient digestion and absorption, recent work 
has identified the intestine as a key organ for the clearance of excess sterols (van der 
Velde et al., 2007; van der Veen et al., 2009; Lo Sasso et al., 2010). The mechanisms that 
underlie this transintestinal cholesterol efflux, however, remain poorly understood (van 
der Velde et al., 2010). This study identifies magro as a key factor required in the 
intestine to promote the clearance of excess sterols. We also show that magro has region-
specific enzymatic activities in the intestine that correspond to the major lipid metabolic 
functions of its upstream regulator, the nuclear receptor DHR96. Below we discuss these 
activities of Magro, relate them to its mammalian homolog, LipA, and describe how 
studies of magro regulation and function can provide insights into the mechanisms by 
which the intestine coordinates TAG and cholesterol homeostasis. 
 
Magro and LipA share conserved functions in  
maintaining lipid homeostasis 
Although a number of recent genetic studies have focused on understanding the 
regulation of lipid metabolism in Drosophila, relatively little is known about the 
mechanisms that control cholesterol levels in this organism, and nothing is known about 
how TAG and cholesterol homeostasis might be coordinated. Genetic studies of 
cholesterol homeostasis in Drosophila have focused primarily on the Niemann-Pick 
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(NPC) disease gene homologs, with the Drosophila ortholog of vertebrate NPC1, npc1a, 
and two of the eight fly NPC2 homologs, npc2a and npc2b, playing important roles in 
intracellular cholesterol trafficking and synthesis of the steroid hormone 20-
hydroxyecdysone (Fluegel et al., 2006; Huang et al., 2007). In contrast, functions for 
npc1b are restricted to the intestine, where it is essential for dietary cholesterol absorption, 
much like its mammalian ortholog NPC1L1 (Voght et al., 2007). Interestingly, most of 
the Drosophila NPC genes are regulated by the DHR96 nuclear receptor, which plays a 
central role in cholesterol metabolism. DHR96 mutants accumulate excess sterol, in part 
due to a failure to properly repress npc1b expression in the intestine (Horner et al., 2009). 
DHR96 also regulates many other genes that contribute to cholesterol uptake, trafficking, 
and storage, including the LipA homolog magro. The studies described here identify 
DHR96 regulation of cholesterol clearance through magro as an important mechanism for 
intestinal cholesterol efflux. 
Animals lacking magro function are lean and exhibit elevated levels of 
cholesterol. These roles for Magro arise from its dual enzymatic activities in the intestine, 
cleaving dietary TAG to facilitate fat absorption and breaking down cholesterol esters to 
promote cholesterol efflux.  These dual functions correspond to those of its mammalian 
homolog LipA, and are consistent with the common fatty acid ester bond that is cleaved 
by the enzyme in both lipid substrates (Goldstein et al., 1975; Ameis et al., 1994). It 
should be noted that all of our studies of magro function have depended on RNAi. 
Although a clear prediction of this work is that magro null mutants would be lethal, due 
to an inability to break down dietary TAG, an analysis of these animals would provide 
valuable confirmation of our RNAi data. Numerous attempts to isolate a targeted null 
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allele, however, were unsuccessful, and the location of magro within an intron of 
CG5195 complicated our ability to isolate deletion mutants by imprecise P-element 
excision. Future genetic studies of magro should provide an important means of 
confirming and extending the results described here with tissue-specific RNAi. 
Interestingly, our studies of magro function in Drosophila reveal parallels with 
LipA function in mouse and humans. Mouse LipA mutants display a lack of stored fat in 
the form of white adipose tissue along with excess cholesterol esters (Du et al., 1998; Du 
et al., 2001), reflecting the major defects in magro mutants. Similar phenotypes are seen 
in patients suffering from the human lipid disorders CESD and Wolman’s disease, which 
are caused by mutations in LipA (Burke and Schubert, 1972). Patients with Wolman’s 
disease also have intestinal malabsorption, which may be related to the defects in lipid 
uptake that we observe in magro mutants. In addition to these shared phenotypes, 
however, mammalian LipA mutants display massive accumulations of lipid in the liver, 
spleen, and intestine – defects that are not apparent in magro mutant flies (Du et al., 
2001). Nonetheless, the parallels between Magro and LipA function in flies and humans 
establish Drosophila as a system to further our understanding of CESD and  Wolman’s 
disease, and define the ancestral function for this class of acid lipases, demonstrating 
their central role in the intestine to coordinate TAG and cholesterol homeostasis. 
 
Magro has region-specific functions in the intestine 
In contrast to the detailed studies of LipA enzymatic functions, we have a 
relatively poor understanding of its cellular roles in the animal. Our studies of Magro 
have shown that the TAG lipase and cholesterol esterase activities of this enzyme act in 
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distinct regions of the intestine to maintain homeostasis. A genomic copy of Magro 
tagged with GFP reveals a low level of expression throughout the intestine, visible as 
punctate cytoplasmic staining in the enterocytes (Figure 3.2B). In addition, Magro-GFP is 
abundantly expressed in the large outer columnar cells in the anterior half of the 
proventriculus (Figure 3.2A). Interestingly, we also see a stream of large acidic vesicles 
that originate from this region of high expression and move in a posterior direction 
toward the lumen of the intestine (Figure 3.2 F-H, Figure 3.6). Disruption of magro 
function specifically in the proventriculus blocks its TAG lipolytic activity, but has no 
effect on the levels of cholesterol in these animals (Figure 3.4A,B). In contrast, magro 
RNAi throughout the intestine affects both TAG and cholesterol homeostasis, suggesting 
that the low level of Magro expression in the enterocytes is critical for intestinal 
cholesterol efflux (Figure 3.1D)(Sieber and Thummel, 2009). These region-specific 
functions of Magro are consistent with our dietary supplementation studies with 
pancreatin and Orlistat, which show that TAG lipolysis in the lumen of the intestine is 
required for proper fat uptake while cholesterol esterase activity in the lumen is 
dispensable for cholesterol homeostasis (Figure 3.3, Figure 3.7). 
 The apparent vesicular trafficking of Magro in the proventriculus is consistent 
with the cells at the anterior end of this structure (referred to as the cardia) having 
secretory functions. Classic studies have shown that the peritrophic matrix arises from 
these cells and is deposited into the lumen that lies between the outer and inner cell layers 
of the proventriculus (King, 1988) (Figure 3.5). The peritrophic matrix is a meshwork of 
chitin and glycoproteins that provides a protective lining within the gut, much like the 
mucosal layer of the mammalian intestine (Hegedus et al., 2009). The observation that 
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the Magro-GFP vesicles reside in the same region of the proventriculus as the developing 
peritrophic matrix suggests that they are synthesized and exported into the lumen of the 
gut in a similar manner. This also raises the possibility that the digestive enzymes that are 
embedded in the peritrophic matrix may originate from vesicular trafficking in the 
proventriculus. Many genes with predicted digestive functions, including glucosidases, 
mannosidases, and endopeptidases, are regulated by DHR96 and expressed in the 
intestine, like magro (Sieber and Thummel, 2009). Several genes that contribute to the 
peritrophic matrix are also regulated by DHR96. It would be interesting to determine if 
these proteins are synthesized and secreted in a coordinated manner by the cardia in the 
proventriculus. 
In contrast to the role of Magro in the proventriculus to promote dietary TAG 
hydrolysis, this enzyme acts outside the proventriculus in the intestine to remove excess 
cholesterol. The expression of Magro in the enterocytes provides a possible mechanism 
to provide this function.  We propose that magro acts as a cholesterol esterase in these 
cells, breaking down stored cholesterol to facilitate its elimination from the intestine. This 
model is consistent with the neutral lipid stores that are known to reside in the 
Drosophila intestine, second only to the fat body. It is also consistent with recent 
evidence that LipA acts as cholesterol esterase in macrophage foam cells to promote 
cholesterol efflux (Ouimet et al., 2011), and suggests that LipA may exert a similar role 






DHR96 and magro provide a novel mechanism for  
intestinal cholesterol efflux 
Like DHR96, mammalian LXR nuclear receptors can control cholesterol levels 
through the intestine, with LXR activation in this tissue resulting in a dramatic increase in 
fecal sterol excretion that correlates with increased expression of the ABCG5/ABCG8 bile 
acid transporter (van der Veen et al., 2009; Lo Sasso et al., 2010). This observation 
suggests that LXR promotes reverse cholesterol transport in this tissue, which represents 
the best understood mechanism for eliminating excess cholesterol from the body. Reverse 
cholesterol transport involves HDL-mediated transport of cholesterol from peripheral 
tissues to the hepatobiliary tract, leading to the removal of excess sterol by biliary 
excretion from the body. LXR activation of fecal sterol excretion, however, proceeds 
normally in abcb4 mutant mice, which have severely impaired biliary cholesterol 
secretion (Kruit et al., 2005). Similarly, abcg5/abcg8 double mutants, which have highly 
reduced biliary cholesterol excretion, have relatively normal levels of fecal sterols (Yu et 
al., 2002).  These and other studies have challenged the importance of reverse cholesterol 
transport for cholesterol excretion and have led to the proposal that the intestine may play 
a more direct role in this process (van der Velde et al., 2010). Indeed, intestinal perfusion 
studies in mice have demonstrated that up to 60% of fecal sterols can be directly excreted 
from the proximal intestine (van der Velde et al., 2007). Taken together, these studies are 
shifting the focus of cholesterol efflux toward the intestine and implicate a central role for 
LXR in regulating this poorly understood pathway.   
Our work provides a new context to understand the role of LXR receptors in 
intestinal physiology. We show that restoring magro expression in the intestine of 
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DHR96 mutants is sufficient to prevent the accumulation of excess sterols (Figure 3.4C). 
This study establishes the importance of intestinal cholesterol esterase activity in clearing 
excess sterol from the body and suggests that acid lipases such as LipA may function 
downstream from mammalian LXR to maintain cholesterol homeostasis. Although there 
is no direct evidence that LXR regulates LipA expression, a recent study has shown that 
elevated levels of oxidized LDL can repress LipA expression in endothelial cells, and this 
effect can be reversed by treatment with LXR agonists (Heltianu et al., 2011). Further 
studies are required to determine if the regulatory links between LXR, LipA, and 
cholesterol homeostasis have been conserved through evolution, and if Drosophila can be 
used as a simple model system to better define the mechanisms of transintestinal 
cholesterol efflux.  
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TRANSGENERATIONAL METABOLIC REPROGRAMMING  







 The ability to sense physiological state and regulate specific changes to 
metabolism is central to all aspects of animal life, balancing energy and biosynthesis 
needs with dietary nutrient uptake, synthesis, and catabolism. Consistent with these 
essential functions, metabolic dysfunction has been associated with a number of different 
forms of human disease such as cardiovascular disease and cancer (CDC, 2011; WHO, 
2006). The astonishing rate at which metabolic disorders are increasing in frequency, 
however, exceeds the influence of simple genetic and environmental factors alone, 
suggesting that other mechanisms contribute to the increased prevalence of these 
disorders. One such factor is the remarkable correlation between metabolic status of the 
parent and that of their progeny. Numerous studies have described this phenomenon of 
nutritional or metabolic programming, demonstrating correlations between poor nutrition 
in pregnant mothers and metabolic disorders in the resulting adult progeny, along with an 
increased incidence of cancer, heart disease, diabetes and obesity (Langley-Evans, 2009) 
(Warner and Ozanne, 2010). These correlations are thought to arise from poor maternal 
nutrition and its effect on the developing fetus. One of the most extensive studies centers 
on the Dutch Hunger Winter, which affected a group of individuals in the Netherlands 
who were born during a Nazi military embargo on food and supplies during the winter of 
1944-1945 (Schulz, 2010). During this period, pregnant women were subjected to 
temporary but severe famine, with the offspring rapidly returning to a normal diet that 
extended into adulthood. Individuals born during this period frequently displayed 
significant increases in total cholesterol and triglycerides (Lumey et al., 2009) (de Rooij 
et al., 2007) (Painter et al., 2005), accompanied by an elevated incidence of obesity, 
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diabetes, heart disease, and cancer (Kahn et al., 2009; Park et al., 2008). These 
observations are similar to those seen in the offspring of rodents subjected to temporary 
nutrient depletion (Langley-Evans, 2009) (Burdge and Lillycrop, 2010; Burdge et al., 
2008; Lillycrop, 2011; Warner and Ozanne, 2010). Taken together, these results are 
interpreted as maladaptation, in which a poor nutritional environment for the fetus 
establishes a metabolic state that is carried through into adulthood, anticipating that the 
poor environment will continue. If, however, the nutritional environment improves after 
birth, then the metabolic state of the progeny is no longer matched to the environment, 
leading to metabolic dysfunction.  
 A molecular foundation to explain this phenomenon has emerged in recent years, 
suggesting that chromatin regulation plays a central role in the transgenerational 
inheritance of metabolic state.  Numerous studies in mice and rats have shown that 
changes in parental nutrition can have an impact on the transcription of key metabolic 
transcription factors that correlates with changes in epigenetic marks at the promoters of 
these genes (Warner and Ozanne, 2010). For example, when pregnant mice are fed a diet 
low in protein content, the resulting progeny display an ~10-30% reduction in DNA 
methylation of the glucocorticoid receptor and PPARα promoters in the liver as well as 
an increase in the expression of these factors and their target genes (Burdge et al., 2007). 
Other studies have reported an increased incidence of diabetes in the adult F1 generation, 
along with changes in histone acetylation and H3K4 and H3K9 methylation in the 
GLUT4, glucocorticoid receptor, and Pdx1 promoters (Lillycrop et al., 2007; Park et al., 
2008; Raychaudhuri et al., 2008). Links have also been made between reduced hepatic 
Cyp7a1 expression, increased H3K9 methylation, and elevated cholesterol levels (Sohi et 
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al., 2011). Overall these studies support the model that the metabolic state of the mother 
establishes a specific epigenetic program in the progeny that is maintained in the 
subsequent generation and helps dictate metabolic state. These studies, however, are all 
correlative and little is known about the functional effects of these changes in chromatin 
state on the progeny. For example, DNA methylation is commonly associated with gene 
expression changes; however, it remains unclear if DNA methylation is required for 
changes in gene expression in response to parental diet. In addition, given the in utero 
link between fetal metabolism and the metabolic state of the mother, it remains unclear if 
the effects observed in these studies are the result of a transmissible change in chromatin 
state between parental and progeny generations or if poor fetal metabolism initiates a 
change in metabolic state that persists into adulthood. These questions were addressed 
recently in a study investigating the paternal contribution to transgenerational metabolic 
reprogramming (Carone et al., 2010). The offspring of male mice fed a low-protein diet 
display a transcriptional profile characterized by up-regulation of lipid biosynthetic 
pathways and down-regulation of hepatic PPARα expression. While no effects on hepatic 
TAG and fatty acid levels were observed, these animals displayed reduced hepatic 
cholesterol, similar to the rat studies. These effects were correlated with a slight ~15% 
increase in DNA methylation of an intergenic CpG island located 50 kb upstream from 
the PPARα promotor in the offspring. The role of this region in PPARa regulation, 
however, remains unclear. In addition, a recent study showed that when adult male mice 
are fed a chronic high fat diet, female progeny of these mice exhibit defects in glucose 
tolerance that correlates with a slight decrease in islet cell mass, suggesting that both 
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nutrient depletion as well as nutrient excess can stimulate transgenerational effects on 
metabolism (Ng et al., 2010).  
 In the course of my studies of DHR96 and magro, I noticed that wild-type flies 
display significant changes in absolute levels of TAG between experiments, and that 
these changes were not always apparent in the DHR96 mutant. A series of studies 
revealed that these changes in TAG levels were not due to nutritional effects on that 
generation of flies, but rather reflected the health and nutrition of their parents. As a 
result, I began experiments to determine if the transgenerational inheritance of metabolic 
state defined in mammals can also occur in Drosophila. My data indicate that when 
parental flies are fed a nutrient poor diet, the resulting progeny show a 2-fold increase in 
whole animal TAG levels.  Furthermore, mutants lacking DHR96 are unable to mediate 
these transgenerational effects, suggesting that DHR96 is a key factor in this process. 
Based on mammalian studies, these transgenerational effects on metabolism are likely 
transduced by changes in chromatin state. Consistent with this hypothesis, animals 
heterozygous for a strong loss-of-function mutation in HP1 exhibit a significantly 
disrupted transgenerational response. This observation provides the first genetic evidence 
of a functional role for chromatin state in transgenerational metabolic reprogramming. 
My data support the model that transgenerational changes in chromatin state adjust the 
metabolic state of the progeny to provide them with a physiological advantage for 






Materials and methods 
Fly stocks 
Fly stocks used in this study include: Canton S, DHR961 (King-Jones et al., 2006), 
and Su(var)2055/CyO(Eissenberg et al., 1992), which was a gift from Gunter Rueter. 
 
Metabolic conditioning parameters  
Our strategy for metabolic programming is depicted in Figure 4.1. To determine 
the effects of parental diet on the metabolic status of their progeny in Drosophila, I set up 
crosses of 20 mature male and 20 mature female flies of the same genotype. These 
matings were conditioned on one of three media: SD (semidefined complete media), SY 
(sucrose/yeast extract minimal media), or SY– (lipid depleted sucrose/yeast extract 
minimal media) for 7-10 days. After conditioning, these flies were transferred to SD 
complete media and allowed to lay progeny for 3-5 days, after which the adults were 
discarded. The resulting progeny were allowed to develop on the SD diet until eclosion 
and then collected, transferred to a new SD media vial, and aged for 7 days. Once 
matured, the adult males were either collected for metabolite measurements (5 




Metabolite measurements were conducted by collecting newly-eclosed adult male 
flies and aging them 5-7 days prior to use for all experiments. TAG and cholesterol 





Figure 4.1 Diagram of the transgenerational metabolic conditioning regimen  
 
This model depicts the conditioning paradigm used to determine the effects of changes in 
parental diet on the metabolic state of the progeny. Mature adult flies were mated and 
conditioned for 7-10 days on one of three media, SD, SY, or SY-lipids (SY-). These 
conditioned adults were then allowed to lay eggs for 3-5 days on rich SD media, after 
which they were discarded. The resulting progeny were allowed to develop and mature 
on the SD media, after which the adults were collected and assayed for metabolite and 




Glycogen and trehalose measurements were conducted as described (Tennessen et al., 
2011). All results shown are derived from 12 samples of five animals collected from each 
genotype under each condition, and repeated at least three times. A representative 
experiment is shown in each figure. 
 
Media recipes 
 Semidefined media was made by combining 10 g agar (Sigma), 40 g cornmeal, 80 
g of brewers yeast (Fleischmann's), 20 g of yeast extract (Sigma), 20 g of peptone 
(Sigma), 30 g of sucrose (Sigma), 60 g of dextrose (Sigma), 0.5 g of MgSO4, and 0.5 g of 
CaCl2 in a 2 liter flask. The volume was raised to 1 liter with ddH2O, mixed, and 
microwaved until boiling. Once boiling, the mixture was microwaved for an additional 1-
2 minutes to ensure that the agar had melted. The food was then allowed to cool until 
~40oC, then 6 mls of propionic acid and 10 mls of 10% tegosept were added. The food 
was mixed and dispensed into vials.  
 SY media was made by adding 30 g of yeast extract (Sigma), 30 g sucrose 
(Sigma), and 3 g of agar (Sigma) into a 1 liter flask. The volume was raised to 300 mls 
and microwaved until boiling. Once boiling, the mixture was microwaved an additional 1 
minute to ensure the agar had melted, and allowed to cool to ~40oC. Once cooled, 1.8 mls 
of propionic acid and 3 mls of 10% tegosept were added. The food was then mixed and 
dispensed into vials.  
 To make lipid depleted SY–, yeast extract and agar were lipid extracted with two 
volumes of chloroform overnight in a fume hood. The following day, the yeast extract 
and agar were filtered with Whatman #1 paper and extracted a second time with two 
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volumes of chloroform for 4 hours. After the second extraction, the yeast extract and agar 
were filtered with Whatman #1 paper and placed uncovered in a fume hood for 3 days to 
allow the chloroform to evaporate completely, before being used to make SY– media as 
described above for SY.  
 
Results 
Parental diet dictates changes in stored energy in the progeny  
 To determine if parental diet influences the metabolic state of their progeny in 
Drosophila, matings of wild-type flies were set up and conditioned for 7-10 days on 
either semidefined (SD) complete media, sucrose/yeast extract (SY) minimal media, or 
lipid depleted sucrose/yeast extract (SY–).  Once conditioned, progeny from these 
animals were collected and allowed to develop and mature on SD complete media 
(Figure 4.1). I then assayed the adult males for TAG and found that, relative to the SD 
unconditioned controls, progeny whose parents were subjected to either the SY or SY– 
minimal media exhibited a significant ~2-fold increase in TAG levels (Figure 4.2A). In 
contrast, I observed a significant decrease in glycogen levels in these animals, suggesting 
that transient exposure to a minimal diet results in a shift in the forms of stored energy in 






Figure 4.2 TAG and glycogen levels in the progeny of Canton S, DHR961, and 
HP15/CyO parents.  
 
Canton S wild-type flies, DHR961 mutants, and HP15/CyO transheterozygous animals 
were subjected to the conditioning regimen described in Figure 4.1. The resulting mature 
adult progeny were assayed for TAG (A) or glycogen levels (B). The data presented are 
depicted as fold change relative to the control that was maintained continuously on the 





DHR96 and HP1 are required to mediate the effects of parental diet 
 on the metabolic state of their progeny 
My initial studies suggested that mutants lacking DHR96 might be resistant to 
changes in TAG levels in response to changes in parental diet. When DHR96 mutant 
parents are subjected to our standard conditioning regimen (Figure 4.1), the resulting 
progeny display similar changes in glycogen levels to those seen in wild-type animals 
(Figure 4.2B). These mutant progeny, however, do not exhibit an increase in TAG levels 
when their parents are exposed to either SY or SY– relative to the SD unconditioned 
controls, indicating a role for DHR96 in mediating this transgenerational response to 
parental diet (Figure 4.2A,B).  In contrast, animals heterozygous for a loss-of-function 
mutation in HP1 (Su(var)205) display an inverted response to parental diet. When 
parental animals are conditioned using the previously described regimen (Figure 4.1), the 
HP1 heterozygote progeny from parents subjected to the SY diets exhibit a significant 
~2-3 fold decrease in whole animal TAG, in contrast to the increased TAG levels seen in 
wild-type flies (Figure 4.2A). This result suggests that HP1 contributes to the metabolic 
reprogramming of progeny in response to parental diet. 
 
Excess cholesterol accumulation in the DHR96 mutant is 
 dependent on parental diet 
Given that TAG and cholesterol metabolism are tightly coordinated by multiple 
mechanisms, I hypothesized that cholesterol homeostasis might also be influenced by 
parental diet.  The progeny of wild-type and HP1 heterozygous animals, however, show 





Figure 4.3 Cholesterol levels in the progeny of Canton S, DHR961, and HP15/CyO 
parents.  
 
Canton S wild-type flies, DHR961 mutants, and HP15/CyO transheterozygous animals 
were subjected to the conditioning regimen described in Figure 4.1. The resulting adult 
progeny were assayed for total cholesterol levels.  The data presented are depicted as fold 
change relative to the control that was maintained continuously on the SD media.  Error 






that TAG metabolism is being specifically affected by parental diet independent of the 
mechanisms that control cholesterol levels (Figure 4.3).  In contrast, when DHR96 
mutant parents are subjected to lipid depleted SY– media, the resulting progeny no longer 
exhibit the elevated levels of cholesterol that are normally seen in DHR96 mutants 
indicating that defects in cholesterol homeostasis observed in the DHR96 mutant are 
influenced by the lipid content of the parental diet. (Bujold et al., 2010) (Horner et al., 
2009) (Figure 4.3). 
 
DHR96 and HP1 display sex-specific parental roles in the 
transgenerational regulation of metabolism 
 While my data define roles for both DHR96 and HP1 in mediating the effects of 
parental diet on the metabolic state of their progeny, it remains unclear whether these 
genes function in the parents or the progeny.  I determined if DHR96 has a role in the 
parental generation by setting up reciprocal matings between DHR96 mutants and wild-
type Canton S animals and conditioning these crosses as described (Figure 4.1). 
Interestingly, while heterozyogous progeny from DHR96 mutant mothers display a wild-
type response to parental diet, heterozyogous progeny from DHR96 mutant fathers no 
longer display this phenotype, but rather appear to recapitulate my previous result with 
DHR96 homozygous mutants (Figure 4.4). These data suggest that DHR96 functions 
primarily in the male parents to facilitate its role in storing TAG in response to parental 
diet. Conversely, when I set up reciprocal crosses between HP15/CyO and Canton S 





Figure 4.4 Parent-specific effects of DHR96 and HP1 in the transgenerational 
metabolic response.  
 
(A) Reciprocal crosses were set up between Canton S and DHR961 mutants. These 
matings were subjected to the same conditioning regimen depicted in Figure 4.1. The 
resulting mature adult progeny were assayed for total TAG levels. (B) The same was 
done using reciprocal crosses between Canton S and HP15/CyO animals, measuring TAG 
levels in the progeny. The data presented are depicted as fold change relative to the 





seen in my original studies of HP1 heterozygotes was recapitulated with HP15/CyO 
mothers, suggesting that HP1 is required in the parental female for a wild-type response 
to parental diet (Figure 4.4). These haplo-insufficient effects are consistent with the 
previously described dose-dependent effects of HP1 on position effect variegation.  
Taken together these results suggest that, in response to metabolic status, DHR96 and 
HP1 mediate signals through both parents to control the transgenerational metabolic state 
of their progeny.   
 
Parental diet influences metabolic gene expression in their progeny  
 As a means to identify a molecular mechanism for these transgenerational effects 
on metabolism, I conditioned Canton S, DHR96 mutant, and HP15/CyO animals and 
collected RNA from the resulting adult progeny.  Transcript levels of a number of known 
metabolic genes were examined by northern blot hybridization, focusing on genes 
regulated by DHR96 (Figure 4.5A). Interestingly, several of these genes significantly 
change their expression in response to parental diet, including magro and two genes that 
encode predicted glycosyl hydrolase enzymes that contribute to carbohydrate break 
down: CG9466 and CG9468. DHR96 expression is also modulated by parental diet, 
suggesting that, in addition to its role in the parental male, mis-regulation of DHR96 may 
also impact the metabolic status of the progeny (Figure 4.5B). In contrast, the transcripts 
of other metabolic transcriptional regulators such as Sir2 and HNF4 do not appear to be 
affected by parental diet, suggesting that DHR96 has a specific role in this process. 
Furthermore, the transcript levels of these genes do not change in response to parental 





Figure 4.5 Transcriptional regulation of metabolic gene expression is dependent on 
parental diet.  
 
(A) Canton S wild-type flies, DHR961 mutants, and HP15/CyO transheterozygous animals 
were subjected to the conditioning regimen described in Figure 4.1. The resulting adult 
progeny were assayed by northern blot hybridization to detect the expression of CG9468, 
CG9466, and magro mRNA. Hybridization to detect rp49 mRNA is shown as a loading 
control.  (B) The expression of three known transcriptional regulators of metabolism, 
DHR96, HNF4, and Sir2, was assayed in these same RNA samples.  Hybridization to 




parental diet.  In contrast, HP15/CyO animals display a disrupted, in some cases 
completely reversed, transcriptional response to parental diet, consistent with the 
transgenerational metabolic defects I observe in these animals.   
 
Parental diet influences the transcriptional regulation of  
metabolic genes in larvae 
 While my data shows that parental diet influences both the metabolic state and 
transcription of metabolic genes in the resulting adult progeny, it remains unclear 
whether these effects manifest in the adult or arise earlier in development and persist 
throughout life. To distinguish between these possibilities, I conditioned Canton S and 
DHR96 mutants using the same regimen as described above (Figure 4.1), but this time I 
collected early wandering third instar larvae for northern blot hybridization analysis.  I 
examined the expression of a number of metabolic genes, focusing on genes known to be 
regulated by DHR96, including: a Drosophila NPC2 homolog CG3934, the intestinal 
endopeptidase Jon99Fi, CG9466 and CG9468, which encode predicted glycosyl 
hydrolase enzymes, and magro (Figure 4.6). As I saw previously, all of these genes, with 
the exception of CG3934, exhibit some form of transcriptional regulation in response to 
changing parental diet, suggesting that the effects I observed on metabolic status likely 
arise early in development and persist throughout the life of the animal (Figure 4.6). 
Furthermore, these transcriptional changes in response to parental diet appear disrupted in 
the DHR96 mutant (Figure 4.6).  My studies, however, are limited to only a few genes 





Figure 4.6 The expression of metabolic genes in larvae is dependent on parental diet.  
 
Canton S wild-type flies and DHR961 mutants were subjected to the conditioning regimen 
described in Figure 4.1. The resulting late third instar larval progeny were assayed by 
northern blot hybridization to detect the expression of  Jon99Fi, CG3934, CG9466, 
CG9468, and magro mRNA. Hybridization to detect rp49 and pepck mRNA is shown as 







 While studies of transgenerational effects on progeny metabolism have identified 
correlations between change in gene expression, chromatin modifications, and 
physiological effects, these studied are complicated by the limitation of the system. For  
example, due to the in utero metabolism link between the fetus and mother, 
understanding whether the transgenerational metabolic effects observed are the result of a 
transmitted signal from mother to progeny or they arise from disrupting the metabolic 
status in the womb itself remain unclear. Drosophila, however, does not maintain an in 
utero link during embryogenesis. Furthermore, the fly has multiple checkpoints that 
monitor metabolic state in the germline, if metabolic state is disrupted the germline stem 
cells stop dividing and the developing oocytes arrest and undergo apoptosis	  (Buszczak et 
al., 2002; Drummond-Barbosa and Spradling, 2001; McLeod et al., 2010). As a result the 
fly provides an ideal model for molecular and genetic characterization of the mechanisms 
that mediate these transgenerational effects on metabolism.  
 My initial studies in flies have established an experimental paradigm that allows 
us to begin to identify and characterize the mechanisms involved in the transgenerational 
regulation of progeny metabolism by parental diet. These studies show when parental 
flies are fed a nutrient poor diet for 7-10 days the resulting progeny, despite being fed a 
standard media throughout their life, exhibit a significant increase in TAG and a 
significant decrease in whole animal glycogen levels. These data indicate that when the 
parental generation is grown on a poor nutrient diet the progeny exhibit a redistribution of 
stored energy, favoring high fat storage at the expense of stored carbohydrates. 
Furthermore, these effects are consistent with studies in mice and humans that show 
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similar effects of parental diet ion the metabolic status of the progeny (Carone et al., 
2010; Langley-Evans, 2009; Ng et al., 2010; Warner and Ozanne, 2010). These data also 
suggest that parental metabolic/ nutritional status induces this redistribution in stored 
energy to give the progeny a physiological advantage to survive in the environment they 
are born into. However, this hypothesis has not been tested.  
 Previous work in mammals has identified correlations between these 
transgenerational metabolic responses and changes in DNA methylation. However, the 
data supporting this hypothesis are only correlative. For example, multiple studies have 
shown that PPARα expression changes in response to parental diet. However a recent 
mouse study has shown that DNA methylation state change only about 15% at a CpG 
island thought to be a PPARα enhancer region, suggesting that DNA methylation is not 
sufficient to explain the changes in gene expression observed in these mice. In addition, 
studies of the human IGF2 loci, one of the best-characterized epigenetically regulated 
loci in mammals, show only a small 5-10% change CpG island methylation supporting 
the hypothesis that other processes such as histone tail modification may play important 
roles in this transgenerational metabolic response. While DNA methylation is absent in 
flies after the first few hours of embryogenesis, flies do provide an excellent means to 
address the regulation of chromatin state. In fact, many of the best characterized 
regulators of chromatin state, such as the HP1 and polycomb complexes, were first 
identified and characterize in Drosophila (Eissenberg et al., 1990; Lewis, 1978; 
Tschiersch et al., 1994). My data, for the first time, provide functional evidence for the 
role of chromatin state in the transgenerational regulation of metabolism in response to 
parental diet. When HP15/CYO parental animals are fed a nutrient poor diet the resulting 
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heterozygous progeny no longer display TAG accumulation, but instead display a 
decrease in TAG levels when the parents were fed a nutrient poor diet. These data are 
consistent with a role in the parent for chromatin regulation mediating transgenerational 
effects on metabolism and suggests that the HP1 chromatin-remodeling complex may be 
involved in this process.  
 Although previous studies in mammals have implicated transcriptional regulation 
of nuclear receptors, such as the glucocorticoid receptor and PPARα, as a possible 
mechanism for mediating changes to metabolism in the progeny in response to parental 
diet, there are no genetic studies that support this hypothesis. Although the Drosophila 
genome does not encode clear orthologs for these receptors, my studies have shown that 
the expression of the Drosophila LXR homolog, DHR96, is modulated in response to 
parental diet. Furthermore, when DHR96 mutant parents are fed a poor nutrient diet, the 
resulting progeny exhibit no changes in TAG levels in response to parental diet despite 
the progeny being grown on a complete media suggesting that DHR96 is an essential 
factor required to mediate this response. This defect in transgenerational TAG response 
correlates with the inability of DHR96 target genes to change their expression in response 
to parental diet in the DHR96 mutant. However, the functional targets for DHR96 in 
mediating transgenerational metabolic effects have not been identified. Taken together 
these data indicate that, in conjunction with being regulated on the transcriptional level in 
response to parental diet, nuclear receptors like DHR96 can function in the parental 
generation to mediate this transgenerational metabolic response. While my work defines 
a role for DHR96 in the parent to facilitate this transgenerational metabolic response to 
parental diet, my data also suggest that DHR96 may function in the progeny to play a role 
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in this response. However, this hypothesis has not been tested. Previous studies have 
shown that nuclear receptors function to regulate transcription, in part, through the 
recruitment of well characterized chromatin remodeling complexes such as: SMRT, 
NCoR, SWI/SNF, GCN5/PCAF, CBP, SMCC, and SRC-1/3 (Chen and Evans, 1995; 
Dilworth and Chambon, 2001; Glass and Rosenfeld, 2000; Horlein et al., 1995). This 
ability in conjunction with the nuclear receptor’s capability to sense metabolic status 
suggests nuclear receptors may play a key role in this mediating a metabolic responsive 
signal between generations. Nuclear receptors may function to sense parental metabolic 
status and facilitating changes in chromatin state, through recruitment of known 
chromatin regulating complexes, which can be transmitted into the progeny. These roles 
for DHR96 in chromatin regulation, however, have not yet been investigated.  
My studies of HP1 and DHR96 define roles for both female and male parents in 
facilitating these transgenerational effects on metabolism.  Whereas DHR96 functions in 
the male parent to facilitate its effects on this transgenerational metabolic response, my 
data indicate that the HP1 complex functions in female parents to facilitate its role in the 
process. Taken together these data indicate that distinct molecular mechanism function in 
male and female parents to mediated these effects on progeny metabolism in response to 
parental diet. Further studies characterizing the physiological changes and molecular 
mechanism affected in both male and female parents should shed light on the precise 
mechanisms function in both parents that are required for these effects on progeny 






 These studies establish a framework for the physiological, genetic, and molecular 
dissection of the mechanisms that transduce this transgenerational metabolic response to 
parental diet. Future studies will define the physiological and molecular effects these 
diets have on the parents themselves and how those effects are transmitted to the progeny. 
Genome wide RNA sequencing analysis will be conducted to determine the specific 
aspects of metabolism that are altered in the progeny in response to parental diet. To 
understand the role DHR96 and HP1 in this transgenerational metabolic response to 
parental diet, studies to assess chromatin state in control, DHR96 mutants, and HP1 
heterozygotes will be conducted to define the precise chromatin modifications that 
function to transduce these signals between generations in response to parental diet. 
Overall these initial studies have identified the first factors, DHR96 and HP1, that 
function in the transgenerational regulation of progeny metabolism and provide a 
framework with which to further elucidate the molecular mechanisms involved in 
transducing these transgenerational signals.  
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 Many nuclear receptors in Drosophila have been characterized for their critical 
roles in development. While these studies have defined the essential functions of these 
receptors, surprisingly little is known about their nonessential functions in processes like 
metabolic regulation, which may have significant implications for human disease. My 
studies define a role for the Drosophila DHR96 nuclear receptor in coordinating TAG 
and cholesterol homeostasis, similar to the mammalian LXR receptors. My work 
indicates that DHR96 controls the breakdown of dietary TAG through direct regulation of 
the intestinal lipase Magro. Previous studies have shown that DHR96 functions to sense 
cholesterol levels and maintain cholesterol homeostasis (Bujold et al., 2010; Horner et al., 
2009). Interestingly, in conjunction with its role in breaking down dietary TAG, DHR96 
functions, in part, through magro to maintain cholesterol homeostasis. Magro exhibits a 
high degree of both TAG lipase and cholesterol esterase activity. While magro functions 
in the intestinal lumen to break down dietary TAG, my work indicates that magro acts 
within the cells of the intestine to breakdown stored cholesterol esters as a means to clear 
excess sterols. Overall these studies identify the intestine as a key organ that coordinates 
TAG and cholesterol homeostasis in the fly and define roles for DHR96 and magro in 
both of these processes. 
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magro functions downstream of DHR96 to coordinate TAG  
and cholesterol homeostasis 
 While numerous studies have identified transcription factors such as SREBP and 
LXRs that coordinately regulate TAG and cholesterol homeostasis, it remains unclear 
whether single direct targets of these transcription factors function in both pathways.  
Interestingly, human genetic studies of patients suffering from cholesterol ester storage 
disease, a condition where affected individuals display severely depleted white adipose 
tissue and increased circulating and stored hepatic cholesterol, identified mutations in the 
magro homolog, LipA, as a primary causal factor (Burke and Schubert, 1972; Goldstein 
et al., 1975). Biochemical studies have shown that LipA directly regulates fat and 
cholesterol metabolism through its ability to breakdown triglycerides and stored 
cholesterol esters (Ameis et al., 1994; Goldstein et al., 1975). This cholesterol esterase 
activity of LipA is required to promote the clearance of excess sterols by ABCA1 
dependent cholesterol efflux (Ouimet et al., 2011). My studies of the DHR96 target gene, 
magro, define a similar role for this enzyme in the intestine of the fly to prevent the 
accumulation of excess sterols. However, the precise mechanism of sterol excretion 
remains unknown. Conversely, although the mechanism by which LipA regulates TAG 
homeostasis remains unclear, my studies of Magro suggest that this family of enzymes 
maintain TAG homeostasis by promoting the breakdown of dietary TAG. Consistent with 
a role in in the digestion of dietary lipids, mouse LipA is expressed at high levels in the 
intestinal villi and the exocrine pancreas. Tissue specific functions for LipA in the liver, 
intestine, and pancreas, however, have not yet been investigated (Du et al., 1996). Overall 
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my studies suggest that individual target genes, such as magro, can act downstream of 
nuclear receptors to coordinate multiple aspects of lipid homeostasis. 
 
DHR96 and magro are required for intestinal cholesterol homeostasis 
 Genetic and molecular studies in mice have focused on the liver as an important 
organ for maintaining cholesterol homeostasis by promoting the clearance of excess 
sterols through reverse cholesterol transport	  (Ameis et al., 1994; Du et al., 1998; Peet et 
al., 1998; Repa et al., 2000). In contrast, recent work has shifted attention toward a key 
role for the intestine in this process	  (Lo Sasso et al., 2010; van der Velde et al., 2007). 
Intestinal profusion experiments have defined regions of the intestine that are responsible 
for up to 60% of the sterols excreted into feces. Interestingly, LXR activation has been 
shown to increase the rate of this transintestinal cholesterol excretion. However, the 
molecular mechanism for how cholesterol is excreted from the intestine has not been 
identified	  (Lo Sasso et al., 2010; van der Veen et al., 2009).  
 Consistent with these findings, our studies of DHR96 have identified a similar 
conserved role for this receptor in the intestine to prevent excess sterol accumulation 
(Bujold et al., 2010; Horner et al., 2009). These data also support mammalian data that 
implicate the intestine as a key organ for the excretion of excess sterols. Interestingly, my 
data indicate that, in addition to its established role in the breakdown of dietary fat, 
magro acts downstream of DHR96 to prevent the accumulation of excess sterols. Magro 
appears to execute this dual activity through region-specific functions in the intestine – 
acting in the proventriculus to promote the breakdown of dietary TAG, and likely acting 
in the enterocytes to promote the breakdown of excess cholesterol esters. My studies with 
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DHR96 and magro identify the first factors in the intestine that are required for the 
clearance of excess sterols in the fly. These studies also suggest that LXR regulation of 
LipA in the intestine is an evolutionarily conserved mechanism that maintains cholesterol 
homeostasis.  
 
Does DHR96 function as the Drosophila LXR? 
 Studies in mammals have shown that the mouse LXR nuclear receptors directly 
sense oxysterol levels and coordinate both TAG and cholesterol homeostasis (Janowski et 
al., 1996; Kalaany and Mangelsdorf, 2006). LXR regulates cholesterol homeostasis by 
controlling the clearance of excess liver sterols by promoting bile acid production and 
excretion (Peet et al., 1998; Repa et al., 2002; Yu et al., 2002a; Yu et al., 2002b). In 
addition, LXRs control TAG homeostasis through regulation of SREBP-1c, an essential 
transcriptional regulator that regulates multiple enzymes in the fatty acid and triglyceride 
biosynthetic pathways. While these studies begin to address the roles for LXRs in lipid 
metabolism, much remains to be learned about how other direct targets of LXRs 
contribute to these pathways.   
 The Drosophila genome encodes two nuclear receptors that show significant 
homology to LXR, EcR and DHR96. Previous studies of the Drosophila EcR have shown 
that this receptor functions primarily as an essential signal that drives developmental 
progression in flies, and does not fulfill the metabolic role of LXRs (Karim and Thummel, 
1992; Koelle et al., 1991; Yao et al., 1993).  In contrast, much like LXRs, DHR96 binds 
sterols and regulates both TAG and cholesterol homeostasis (Bujold et al., 2010; Horner 
et al., 2009). While DHR96 does promote TAG accumulation, it does not appear to do so 
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through regulation of SREBP, as in mammals.  Studies in the second chapter of this 
dissertation indicate that DHR96 maintains TAG homeostasis by promoting the 
breakdown of dietary TAG through regulation of the intestinal lipase Magro. While it 
remains unclear whether LXRs can affect TAG metabolism independently of the SREBP-
1c pathway, recent studies have begun to define roles for this receptor in the mouse 
intestine, raising the possibility that LXRs could direct the digestion of dietary TAG 
similar to DHR96	  (Kruit et al., 2005; Lo Sasso et al., 2010; van der Veen et al., 2009).  
 In mammals, hepatic bile acid production and excretion are thought to be the 
primary means of sterol clearance (Yu et al., 2002b). LXRs mediate this process by 
inducing the expression of the bile acid biosynthetic enzyme, Cyp7A, and promoting bile 
acid excretion through regulation of the sterol transporters ABCG5/ABCG8 (Kalaany and 
Mangelsdorf, 2006; Peet et al., 1998; Repa et al., 2002). Interestingly, recent data have 
shown that mutants lacking ABCG5/ABCG8 show a relatively small defect in fecal sterol 
excretion, suggesting that LXRs have additional targets that are important for the 
excretion of excess sterols (Yu et al., 2002a). Consistent with these data, my studies 
indicate that DHR96 functions through magro to regulate the breakdown of stored 
cholesterol esters and promote the clearance of excess sterols.  These data, in conjunction 
with recent evidence that LXRs can act in the intestine to promote the clearance of excess 
sterols in mice (Kruit et al., 2005; Lo Sasso et al., 2010; van der Veen et al., 2009), 
suggest that LXRs exert this effect through the mammalian homolog of magro, LipA. 
Although there is no direct evidence that LXR regulates LipA expression, a recent study 
has shown that elevated levels of oxidized LDL can repress LipA expression in 
endothelial cells, and this effect can be reversed by treatment with LXR agonists 
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(Heltianu et al., 2011).  Further studies are required to determine if the regulatory links 
between LXR, LipA, and cholesterol homeostasis have been conserved through evolution, 
and if Drosophila can be used as a simple model system to better define the mechanisms 
of transintestinal cholesterol efflux. 
 
Parental diet influences the metabolic state of the progeny  
The ability to sense metabolic status and regulate specific aspects of metabolism 
is central to human health and disease. Interestingly, numerous studies in rodents and 
humans have suggested that the metabolic status of the parental generation can have a 
profound effect on their adult progeny	  (Langley-Evans, 2009; Warner and Ozanne, 2010).  
These studies have shown that conditions of nutrient depletion or excess can lead to 
significant defects in the health of their progeny, along with changes in metabolic gene 
expression (Carone et al., 2010; Langley-Evans, 2009; Ng et al., 2010; Warner and 
Ozanne, 2010). Recent studies to determine a biological role for the transgenerational 
regulation of metabolism have suggested that a signal is transmitted to the progeny in 
response to parental metabolic status, establishing a state that allows the progeny to adapt 
to the predicted nutritional environment.  These changes in progeny metabolic status have 
been correlated with changes in DNA methylation and chromatin, suggesting that these 
transgenerational effects on progeny metabolism arise from changes in chromatin state.  
Due to the long generation time and restrictions on modulating diets in mammalian 
systems, it has been difficult to test this hypothesis in mammals.    
During my studies of Drosophila lipid metabolism, I observed changes in TAG 
levels in wild-type animals that appeared to reflect the health and nutrient status of the 
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parental flies. In subsequent experiments, I was able to show that the metabolic status of 
progeny flies is heavily influenced by parental diet. When wild-type parental animals are 
exposed to a poor diet, their resulting progeny, despite being fed a complete media 
throughout their development, accumulate excess TAG. In contrast, glycogen levels drop 
dramatically in these animals. These data suggest that there is a shift in energy storage 
that favors storing higher levels of lipids at the expense of stored carbohydrates. These 
observations are consistent with the hypothesis that the transgenerational regulation of 
metabolism provides an adaptive advantage. When the diets of the parents and progeny, 
however, are mismatched, the offspring are improperly programmed and display 
metabolic dysfunction. While previous studies in mammals have not tested whether 
transgenerational metabolic regulation provides a adaptive advantage, my work in 
Drosophila allows me to test this hypothesis directly.  In conjunction with the effects on 
metabolite levels, I have shown that the expression of a number of predicted metabolic 
genes is dependent on parental diet, suggesting that transcriptional regulation plays a key 
role in mediating these transgenerational effects.  These studies establish a new genetic 
system for characterizing this process as well as a framework for more in-depth 
molecular definition of the mechanisms that facilitate the transgenerational effects on 
metabolism.  
 
HP1 is required to mediate transgenerational metabolic 
effects on the progeny 
 Studies in mice and humans have suggested that the metabolic status of the parent 
induces epigenetic changes that are transmitted to the next generation to help them adapt 
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to their nutritional environment (Heijmans et al., 2008; Lillycrop, 2011; Park et al., 2008; 
Warner and Ozanne, 2010). For example, a recent study has demonstrated changes in 
PPARα expression levels in response to parental diet. The prevailing model is that 
chromatin state is altered in the germline in response to parental metabolic status and the 
resulting changes in chromatin state are transmitted to the progeny where they influence 
metabolic gene expression. These studies, however, have only provided correlations 
between effects on metabolic gene expression in response to parental diet and alterations 
in chromatin state. As a result, the precise mechanisms that underlie this regulation 
remain unclear.  
 Consistent with these studies in mammalian systems, I discovered that animals 
heterozygous for a loss-of-function mutation in the chromatin complex member HP1 no 
longer display an accumulation of TAG in their progeny in response to parental diet. 
These data suggest that HP1 plays a key role in this process and provide the first genetic 
evidence for a role for chromatin state in transducing the transgenerational regulation of 
metabolism. While my work supports the chromatin model of transgenerational 
metabolic regulation, it remains unclear which chromatin modifications are involved in 
establishing this state. Given the links between HP1 and H3K9 histone tail modifications, 
my data suggests that the balance of H3K9 methylation and H3K9 acetylation may 
influence transgenerational metabolic regulation. This has, however, not yet been tested 
on a molecular level. Overall, these studies establish a foundation to undertake more 
comprehensive genetic, molecular, and biochemical studies to fully elucidate the effects 




DHR96 is required for the transgenerational regulation of  
progeny metabolic state  
 While studies in rodents and humans have implicated transcriptional regulation of 
nuclear receptors, such as the glucocorticoid receptor and PPARα, as controlling changes 
in progeny metabolism in response to parental diet, there are no genetic studies that 
support this hypothesis. Although the Drosophila genome does not encode clear 
orthologs for these receptors, my studies have shown that the expression of the 
Drosophila LXR homolog, DHR96, is modulated in response to parental diet. In addition, 
when DHR96 mutant parents are fed a nutrient poor diet, the resulting progeny no longer 
exhibit TAG accumulation in response to changes in parental diet. This correlates with 
the misregulation of key DHR96 target genes. These studies define a critical role for 
DHR96 in regulating the transgenerational inheritance of metabolic state. The exact 
molecular mechanisms, however, require further study. In particular, several studies have 
shown that nuclear receptors mediate their effects on target gene expression through 
interactions with several well-established chromatin remodelers, suggesting that DHR96 
may provide a means of sensing metabolic status in the parental generation and directing 
changes in chromatin state that can be transmitted to the progeny. Taken together, my 
studies provide a new foundation to better understand the role of nuclear receptors in 
transgenerational metabolic regulation and to determine if nuclear receptors provide a 
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